rfhg_152146.1

Basic information about the TSS

---

TSS ID: rfhg_152146.1 TSS ID(Version3): hg_131602.1 hg_131601.1 hg_131599.1 hg_234486.1 hg_131600.1 Species: human Chr: chr12		Start: 56725230 End: 56725397 Strand: -
Source datasets	DRA000914|PRJDB5282|PRJNA615891|PRJNA548673|PRJNA401781 |PRJNA597322|DRA013844|PRJNA4843412
Protocol	CAGE|C1CAGE|TIF-seq2|SLIC_CAGE|ReCappable-seq|RAMPAGE |STRIPE-seq|NETCAGE|oligo_capping
TSS cluster detected*	12

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2564008,EH38E1615976)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000678066.1:0 ENST00000678047.1:0 ENST00000678416.1:0 ENST00000546862.6:0 ENST00000679092.1:0 ENST00000550952.6:0 ENST00000454682.6:0 ENST00000550920.6:0 ENST00000678376.1:0 ENST00000552540.5:0 ENST00000393891.8:0 ENST00000548563.5:0 ENST00000547914.5:0 ENST00000551775.5:0 ENST00000551793.5:0 ENST00000551520.1:0 ENST00000548084.1:0 AK223085:0 AK096699:0 AK293209:0 BC106041:0 AF054187:0 X80909:0 AY911673:0 AK311904:0 AY605660:0 GeneID: 4666 HGNC/MGI_ID: HGNC:7629 UniProt_ID: A0A024RB41 B4DDI8 E9PAV3 F8VZJ2 F8W029 F8W0C7 F8W1N5 H0YHX9 Nearer transcript ids and distances: BC105120:71 BC105122:71 ENST00000546392.6:-119 ENST00000552055.5:194 ENST00000549259.5:311 view more...

Gene_name: nascent polypeptide associated complex subunit alpha Gene_symbol: NACA Gene_synonyms: NACA1 Gene_source: HGNC:7629

TATA-Box annotation

---

Distance to TSS:	-14
Nearest PromoterID:	NM_005594
Entrez ID:	4666
Nearest Unigene:	Hs.505735
Nearest Refseq:	NM_005594
Nearest Ensembl:	ENSG00000196531
Gene Name:	nascent polypeptide associated complex subunit alpha
Gene Alias:	HSD48|NAC-alpha|NACA1|skNAC
Gene Type:	protein-coding
CpG%:	0.077844
GC%:	0.613095
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@NACA p2@NACA p3@NACA p4@NACA p5@NACA p6@NACA p7@NACA
Sample		p1@NACA	p2@NACA	p3@NACA	p4@NACA	p5@NACA	p6@NACA	p7@NACA
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	361.56	272.72	25.71	1.95	4.68	2.34	17.53
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	335.04	272.73	24.48	2.43	4.65	1.21	15.17
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	385.62	296.11	29.90	1.74	4.24	1.54	13.89
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	342.22	248.87	21.21	3.33	2.70	0.83	12.06
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	347.57	273.33	24.75	1.57	4.95	2.02	12.15
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	374.83	295.17	23.26	1.94	4.65	1.74	14.54
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	456.47	429.45	26.15	5.88	4.58	3.27	15.47
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	427.76	350.01	25.68	1.21	4.84	1.21	14.78
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	350.28	292.58	25.00	1.71	4.06	0.85	15.82
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	249.82	257.35	29.56	1.16	3.48	1.74	17.97
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	200.50	217.48	28.30	0.00	2.83	0.40	11.32
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	185.39	203.28	21.95	0.81	4.88	0.41	13.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	244.37	114.12	32.88	2.90	0.48	1.61	3.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	261.46	125.24	33.53	2.86	0.30	0.15	3.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	301.23	126.68	25.91	3.07	0.22	0.66	3.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	227.10	107.89	37.22	2.01	0.00	1.51	3.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	266.46	119.47	26.86	1.97	0.44	0.66	4.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	216.39	101.24	40.07	4.64	0.00	0.84	4.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	186.07	118.36	27.72	1.07	0.53	2.13	3.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	374.30	164.28	32.34	2.56	0.45	1.81	2.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	251.40	127.64	35.95	2.81	0.67	1.47	2.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	317.28	147.94	36.77	2.93	0.86	1.04	5.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	244.30	115.04	30.12	2.07	1.03	0.65	3.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	270.82	117.94	27.91	2.91	1.94	0.73	4.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	295.91	127.45	33.28	2.58	1.03	0.77	3.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	328.22	132.94	37.03	4.43	0.63	0.63	3.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	246.16	125.28	31.32	3.30	1.10	0.00	4.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	385.69	156.30	35.13	5.42	0.71	1.89	2.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	295.26	126.63	33.27	3.23	0.32	0.65	3.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	307.10	141.15	25.88	2.17	0.36	0.54	3.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	247.44	144.24	36.22	3.98	0.42	1.47	3.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	292.88	121.14	26.96	3.71	0.78	0.59	3.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	257.03	120.71	33.55	1.69	0.42	2.11	3.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	349.84	180.28	47.50	4.95	1.32	2.14	4.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	374.91	154.45	31.60	4.86	1.31	1.31	3.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	266.93	121.49	29.51	2.11	0.57	0.96	3.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	314.75	142.66	30.04	2.66	1.02	1.43	3.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	302.63	121.90	27.81	2.82	1.01	0.60	3.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	416.77	157.74	31.33	4.32	0.81	0.81	2.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	333.45	132.51	23.77	2.88	1.68	1.20	2.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	268.43	107.75	28.47	1.88	1.18	1.41	4.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	308.16	142.59	37.04	2.93	0.88	1.17	6.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	410.40	153.74	27.42	5.27	1.48	0.21	2.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	272.91	118.53	29.90	2.80	0.87	1.22	2.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	372.43	138.93	23.29	3.01	1.20	1.20	4.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	363.39	145.40	26.52	7.21	1.40	2.09	3.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	319.56	115.16	26.39	1.92	0.72	0.96	4.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	360.34	140.68	26.82	2.98	0.89	0.89	3.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	270.73	109.15	26.33	1.44	0.24	0.72	3.83
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	359.91	131.23	21.84	3.84	0.61	1.82	2.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	224.63	120.72	28.90	4.51	0.82	1.84	4.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	218.15	88.73	27.35	4.45	0.22	2.00	6.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	1273.29	265.85	55.97	13.99	0.00	13.99	55.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	242.37	90.84	21.65	1.42	1.06	0.71	5.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	247.88	69.92	25.52	1.33	0.33	1.99	3.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	830.55	244.13	56.21	26.01	0.00	13.42	11.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	443.17	122.62	38.58	5.05	1.38	0.92	5.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	220.39	77.14	17.83	1.30	0.65	0.65	3.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	196.23	60.06	11.56	1.61	1.28	0.32	3.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	316.85	108.44	34.58	5.34	0.31	2.51	9.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	207.99	54.29	18.33	0.71	0.00	0.71	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	204.13	58.32	22.43	1.68	0.00	0.56	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	277.06	69.26	28.66	16.72	0.80	9.55	8.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	267.74	66.25	22.76	4.42	0.68	2.04	2.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	232.64	53.29	11.05	1.30	0.00	2.92	2.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	157.61	34.79	15.62	2.48	0.35	0.71	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	1018.33	242.46	64.66	48.49	0.00	16.16	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	1208.31	236.92	102.67	0.00	0.00	23.69	23.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	161.37	40.95	11.21	1.95	0.00	1.46	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	181.98	52.07	17.85	1.98	0.00	2.48	3.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	157.15	53.01	16.42	2.35	0.00	0.00	4.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	178.51	64.58	10.27	2.32	0.33	0.99	2.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	174.16	75.79	10.52	2.17	0.00	1.24	2.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	141.87	53.51	8.26	1.83	0.31	0.61	2.14
Adipocyte - breast, donor1	11376-118A8	147.77	79.19	21.07	0.95	1.11	0.48	7.29
Adipocyte - breast, donor2	11327-117E4	119.68	71.07	16.20	4.65	0.80	1.44	4.17
Adipocyte - omental, donor1	11473-119C6	148.47	96.44	24.30	0.89	0.89	0.13	6.36
Adipocyte - omental, donor2	11474-119C7	159.22	56.06	12.71	5.23	0.00	0.75	3.74
Adipocyte - omental, donor3	11475-119C8	213.01	66.31	12.06	3.01	0.00	1.67	3.35
Adipocyte - perirenal, donor1	11476-119C9	157.58	44.02	22.33	0.00	0.00	0.00	6.38
Adipocyte - subcutaneous, donor1	11259-116F8	127.54	75.87	7.70	1.10	0.00	0.00	6.60
Adipocyte - subcutaneous, donor2	11336-117F4	206.84	143.62	8.58	0.90	0.45	0.00	2.71
Adipocyte - subcutaneous, donor3	11408-118E4	191.15	209.05	17.73	2.26	0.35	1.91	1.22
Adipocyte differentiation, day04, donor1	13019-139D4	160.17	100.72	21.90	0.59	1.96	0.78	5.87
Adipocyte differentiation, day04, donor2	13022-139D7	140.53	60.74	21.11	0.51	0.51	0.77	5.40
Adipocyte differentiation, day04, donor3	13025-139E1	185.11	64.12	11.99	0.84	1.39	0.56	6.41
Adipocyte differentiation, day04, donor4	13028-139E4	169.29	58.19	27.63	0.00	0.59	0.00	6.47
Adipocyte differentiation, day08, donor1	13020-139D5	217.65	123.46	17.94	0.97	0.48	0.16	5.55
Adipocyte differentiation, day08, donor2	13023-139D8	192.36	72.30	19.04	0.97	0.97	0.00	3.55
Adipocyte differentiation, day08, donor3	13026-139E2	159.42	60.25	14.40	1.60	0.53	1.60	4.27
Adipocyte differentiation, day08, donor4	13029-139E5	165.82	60.10	19.48	0.00	0.00	0.56	6.12
Adipocyte differentiation, day12, donor1	13021-139D6	165.11	67.79	16.64	1.25	0.42	0.42	3.74
Adipocyte differentiation, day12, donor2	13024-139D9	134.88	50.74	12.06	0.25	0.00	0.25	4.02
Adipocyte differentiation, day12, donor3	13027-139E3	129.26	52.36	13.09	1.31	0.00	0.00	3.27
Adipocyte differentiation, day12, donor4	13030-139E6	106.26	49.63	7.92	0.00	0.30	0.30	3.35
Alveolar Epithelial Cells, donor1	11510-119G7	85.31	61.22	10.17	0.22	0.66	0.22	3.09
Alveolar Epithelial Cells, donor2	11590-120G6	25.10	15.42	2.51	0.00	0.00	0.00	1.43
Alveolar Epithelial Cells, donor3	11671-122G6	19.17	40.73	5.99	0.00	0.00	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	84.02	37.96	12.41	0.36	0.72	0.18	3.06
Amniotic Epithelial Cells, donor2	11613-122A2	53.55	21.76	8.37	0.00	1.67	0.00	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	72.32	37.19	11.71	0.62	0.41	0.21	0.82
Anulus Pulposus Cell, donor1	11248-116E6	248.88	209.63	44.05	0.92	1.83	0.69	2.86
Anulus Pulposus Cell, donor2	11463-119B5	275.52	116.09	25.47	1.71	0.73	0.24	2.69
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	209.37	116.82	13.93	0.90	0.90	0.00	4.04
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	208.39	121.99	19.97	1.74	0.87	1.30	3.47
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	169.08	107.01	21.40	6.42	2.14	2.14	4.28
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	200.88	114.19	14.95	1.49	0.60	0.90	4.48
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	220.05	123.94	15.18	7.59	1.26	1.26	3.79
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	150.50	118.81	20.46	5.28	0.00	1.32	3.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	173.81	101.04	13.97	0.97	0.00	0.97	3.90
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	204.86	115.05	21.36	1.46	0.49	0.97	3.40
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	159.75	122.34	19.60	7.13	1.19	1.19	4.16
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	224.10	115.25	15.07	3.01	1.13	1.51	2.64
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	219.15	116.83	18.14	2.18	0.73	0.73	6.53
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	144.18	92.78	16.30	0.00	0.00	0.00	2.51
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	206.74	157.32	24.38	0.33	0.33	0.33	5.44
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	221.10	95.54	12.28	2.73	0.00	1.36	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	179.14	129.68	20.21	0.75	1.21	0.60	2.71
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	172.52	124.84	18.22	0.54	2.14	3.21	3.75
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	197.82	104.10	16.06	1.51	0.94	0.94	2.27
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	164.92	117.61	24.06	3.21	1.07	2.14	2.67
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	169.73	108.28	17.56	0.98	1.95	0.98	3.90
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	214.46	110.13	16.75	1.82	1.00	0.83	1.99
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	130.88	114.07	26.42	0.00	1.20	0.00	3.60
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	159.31	92.04	7.08	0.00	0.00	0.00	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	185.94	111.84	15.09	1.89	1.37	0.86	3.60
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	113.26	79.70	20.97	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	212.13	121.36	16.02	1.94	0.49	2.43	6.31
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	237.16	119.53	17.45	1.90	1.52	2.28	3.04
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	152.63	122.35	14.54	4.85	1.21	2.42	6.06
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	211.48	102.61	21.66	1.71	0.00	2.28	2.28
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	178.29	106.46	22.45	1.71	0.64	1.50	3.85
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	154.34	112.79	17.81	2.32	0.77	0.77	3.10
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	198.01	98.06	15.48	1.88	1.41	1.41	2.35
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	173.64	98.72	19.29	1.29	0.32	0.96	2.89
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	143.40	122.71	17.84	0.71	1.43	0.71	2.85
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	190.69	101.78	14.04	1.17	0.58	0.00	3.51
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	184.56	114.71	12.95	1.51	0.60	0.60	3.61
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	163.94	122.36	15.44	1.19	1.19	2.38	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	254.79	135.28	22.38	2.03	1.02	2.03	2.54
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	191.02	128.62	16.55	3.06	0.00	2.29	3.82
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	148.04	111.19	13.34	2.54	0.00	1.27	2.54
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	193.33	112.63	19.85	1.29	0.00	0.86	3.02
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	214.86	114.73	16.09	1.27	0.42	0.85	3.39
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	143.83	114.83	17.11	1.16	0.29	0.58	3.19
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	184.22	116.20	11.34	0.00	0.00	1.89	2.83
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	187.32	110.53	13.05	2.20	0.68	0.51	2.88
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	182.99	106.55	9.27	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	247.17	135.20	12.68	0.00	4.23	2.11	6.34
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	196.83	100.77	13.94	0.43	1.29	0.43	3.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	184.71	125.15	22.86	0.60	0.00	0.60	3.61
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	201.93	112.26	12.39	0.00	0.00	0.00	2.19
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	222.75	125.97	16.55	1.38	1.15	0.69	1.15
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	163.22	119.86	17.85	10.20	0.00	0.00	5.10
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	185.08	182.03	21.36	2.03	1.02	0.76	2.80
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	180.02	114.99	22.71	0.83	0.41	1.24	4.54
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	159.43	116.89	21.11	3.37	0.00	0.61	6.12
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	233.75	117.11	11.47	1.43	0.48	1.43	2.39
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	190.92	100.23	16.19	2.22	0.44	0.44	2.66
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	141.90	109.86	18.31	7.63	3.05	0.00	4.58
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	222.11	95.82	14.95	0.55	1.11	1.66	4.43
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	155.70	103.80	17.48	2.12	0.26	2.12	3.44
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	152.28	120.30	21.08	1.45	0.73	0.36	1.45
Astrocyte - cerebellum, donor1	11500-119F6	93.34	49.13	16.21	0.49	1.23	0.12	5.65
Astrocyte - cerebellum, donor2	11580-120F5	71.37	29.27	10.27	0.00	0.68	0.17	1.37
Astrocyte - cerebellum, donor3	11661-122F5	43.00	27.06	6.71	0.00	1.26	0.21	1.47
Astrocyte - cerebral cortex, donor1	11235-116D2	245.75	108.41	30.33	0.70	3.49	0.00	6.27
Astrocyte - cerebral cortex, donor2	11316-117D2	195.75	129.58	39.47	2.91	1.78	1.62	12.62
Astrocyte - cerebral cortex, donor3	11392-118C6	194.95	95.46	35.20	2.09	1.64	1.04	7.31
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	421.13	311.49	52.76	4.13	1.15	0.92	9.29
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	418.82	312.20	51.74	2.38	4.76	0.38	15.91
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	398.52	323.18	48.59	2.28	2.84	1.48	12.86
Basophils, donor1	12241-129G9	148.81	65.12	15.69	0.26	0.52	0.00	1.83
Basophils, donor2	12242-129H1	348.89	152.26	28.50	0.72	2.16	1.08	2.89
Basophils, donor3	12243-129H2	303.70	107.90	15.14	1.47	0.73	0.15	1.47
Bronchial Epithelial Cell, donor1	11511-119G8	69.42	97.45	5.39	0.22	0.43	0.22	1.29
Bronchial Epithelial Cell, donor2	11591-120G7	33.37	30.17	4.11	0.00	0.00	0.00	1.37
Bronchial Epithelial Cell, donor3	11672-122G7	208.03	186.51	21.52	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	178.88	115.49	9.41	2.51	0.00	0.63	3.14
Bronchial Epithelial Cell, donor5	11457-119A8	91.50	77.77	9.57	0.83	0.21	0.00	1.46
Bronchial Epithelial Cell, donor6	11461-119B3	93.04	107.09	9.67	1.15	0.69	0.69	1.61
Bronchial Epithelial Cell, donor7	11769-123I5	211.98	206.22	23.39	3.06	0.00	1.26	2.16
Burkitt's lymphoma cell line:DAUDI	10422-106C8	414.59	240.12	102.23	1.13	2.37	0.72	25.97
Burkitt's lymphoma cell line:RAJI	10476-106I8	466.74	269.70	73.60	2.10	3.26	1.63	13.28
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	808.07	235.03	54.36	2.88	4.16	0.96	10.23
CD133+ stem cells - cord blood derived, pool1	12223-129E9	858.38	403.34	82.74	10.34	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	271.63	81.72	18.60	1.13	0.56	0.56	1.13
CD14+ Monocytes, donor2	11305-117B9	272.83	77.21	21.16	2.23	0.74	1.86	1.30
CD14+ Monocytes, donor3	11381-118B4	233.59	71.13	17.12	1.32	0.00	1.10	1.54
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	200.11	60.85	24.62	0.28	0.28	0.57	4.81
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	178.17	68.99	23.50	0.76	0.38	0.76	4.93
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	206.45	60.82	24.33	1.97	0.00	0.33	2.96
CD14+ monocytes - mock treated, donor1	11863-125A9	313.09	64.61	24.86	7.08	0.00	1.88	3.61
CD14+ monocytes - mock treated, donor2	11873-125C1	288.77	62.76	15.09	5.13	0.60	3.32	3.02
CD14+ monocytes - mock treated, donor3	11883-125D2	268.16	60.88	17.06	4.50	0.24	1.42	3.79
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	266.66	50.22	12.05	3.85	0.67	1.84	2.34
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	255.86	46.09	16.01	5.52	0.83	1.93	1.38
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	266.28	59.50	11.16	4.46	0.25	0.99	3.72
CD14+ monocytes - treated with BCG, donor1	11860-125A6	253.76	55.80	11.75	5.09	0.39	1.96	2.15
CD14+ monocytes - treated with BCG, donor2	11870-125B7	301.79	71.40	12.29	4.10	0.18	3.56	1.60
CD14+ monocytes - treated with BCG, donor3	11880-125C8	421.55	108.82	21.33	6.96	0.22	3.05	2.61
CD14+ monocytes - treated with Candida, donor1	11868-125B5	298.51	66.49	12.41	1.40	0.00	2.81	1.40
CD14+ monocytes - treated with Candida, donor2	11878-125C6	373.84	79.20	16.90	4.75	0.00	3.70	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	363.87	76.55	14.42	5.55	0.00	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	285.45	54.14	14.13	5.95	0.00	2.23	3.12
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	287.15	48.69	12.77	8.18	0.00	2.00	2.99
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	443.05	84.32	17.49	7.08	0.00	3.12	5.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	307.26	62.46	13.04	7.32	0.46	2.75	1.14
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	317.14	62.66	14.93	4.30	0.23	1.13	2.49
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	248.78	60.67	11.78	3.06	0.87	0.87	1.75
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	263.34	56.76	11.84	3.50	0.27	1.88	2.96
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	334.44	83.04	19.37	8.72	0.17	3.14	2.27
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	286.16	66.49	14.73	4.63	0.00	2.10	2.10
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	250.58	54.01	10.84	4.41	0.00	3.67	0.55
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	222.63	56.01	7.05	4.23	0.00	1.76	1.41
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	236.91	39.49	9.21	3.95	0.00	0.88	1.75
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	231.92	54.75	10.29	5.93	0.17	2.44	1.39
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	277.27	65.04	12.64	8.55	0.37	1.49	1.49
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	465.37	113.81	19.18	5.60	0.65	2.16	2.59
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	200.24	62.24	10.24	4.91	0.41	1.23	1.23
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	337.27	70.24	14.37	2.09	0.00	1.16	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	349.61	86.07	11.83	7.19	0.00	1.16	1.62
CD14+CD16+ Monocytes, donor1	11789-124B7	506.98	127.51	35.31	6.97	0.65	1.31	9.37
CD14+CD16+ Monocytes, donor2	11801-124D1	626.00	200.04	34.19	3.46	0.46	2.54	6.93
CD14+CD16+ Monocytes, donor3	11912-125G4	523.56	120.87	28.59	1.08	0.22	0.87	5.42
CD14+CD16- Monocytes, donor1	11788-124B6	580.69	106.98	35.82	3.43	0.16	1.71	6.07
CD14+CD16- Monocytes, donor2	11799-124C8	489.00	86.10	30.04	3.49	0.00	1.75	4.37
CD14+CD16- Monocytes, donor3	11910-125G2	451.07	78.04	28.54	3.34	0.22	2.01	7.14
CD14-CD16+ Monocytes, donor1	11790-124B8	979.36	325.86	33.17	4.34	3.06	3.57	9.19
CD14-CD16+ Monocytes, donor2	11800-124C9	862.23	296.63	37.33	5.05	2.20	2.85	8.34
CD14-CD16+ Monocytes, donor3	11911-125G3	752.49	242.13	33.06	4.00	1.89	0.84	9.90
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	664.57	162.58	32.52	8.13	2.03	0.00	4.06
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	637.98	102.37	29.83	3.39	0.68	1.36	4.75
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	657.60	125.31	32.10	2.07	2.07	4.14	3.11
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	723.87	122.60	51.17	3.20	0.53	2.67	4.80
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	766.58	127.05	40.74	1.07	2.14	1.07	4.82
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	685.79	108.10	29.48	2.81	0.00	1.40	9.83
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	691.02	120.79	21.18	3.92	1.57	2.35	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	816.02	141.06	38.23	1.32	2.64	1.32	6.59
CD19+ B Cells, donor1	11544-120B5	330.40	96.16	19.73	5.75	0.00	1.64	0.00
CD19+ B Cells, donor2	11624-122B4	314.11	113.17	19.59	5.08	0.73	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	325.11	96.93	12.62	3.03	2.02	3.53	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	491.33	228.29	31.92	2.02	2.83	2.42	12.93
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	389.10	187.36	33.96	1.60	2.00	0.40	10.79
CD34+ Progenitors, donor1	11545-120B6	627.53	214.87	56.23	1.00	0.00	2.01	2.01
CD34+ Progenitors, donor2	11625-122B5	635.97	218.54	46.63	2.25	0.56	1.69	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	810.13	230.34	52.61	2.63	1.50	0.75	6.76
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	765.52	257.50	67.87	2.71	2.48	1.13	6.99
CD4+ T Cells, donor1	11225-116C1	583.43	184.24	26.07	1.79	2.14	1.07	1.07
CD4+ T Cells, donor2	11306-117C1	545.62	143.91	26.33	11.63	2.45	6.12	1.84
CD4+ T Cells, donor3	11382-118B5	386.43	125.66	23.79	6.71	1.83	5.79	2.44
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	545.19	76.32	28.84	5.10	0.77	3.06	3.32
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	497.26	92.08	37.28	3.59	0.45	1.12	4.94
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	469.14	87.68	35.07	1.72	0.57	1.15	4.31
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	1132.60	200.07	27.97	6.64	3.79	1.90	1.42
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	1499.46	238.09	31.60	4.92	4.21	2.81	2.11
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	748.24	135.15	39.55	9.89	3.30	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	349.29	72.84	30.78	3.76	0.29	1.45	6.07
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	270.46	63.89	25.59	3.22	0.68	1.19	2.71
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	224.40	54.65	19.02	3.87	0.48	0.97	2.74
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	609.24	120.14	21.97	2.69	2.69	2.69	1.79
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	766.56	133.12	30.75	4.54	1.75	3.14	3.84
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	577.26	107.36	21.56	2.64	1.32	0.88	3.96
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	464.23	66.20	32.04	2.95	0.42	1.26	2.95
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	268.65	64.41	33.66	2.91	0.21	1.25	4.99
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	292.36	64.49	29.40	2.00	0.00	1.00	4.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	952.04	143.04	42.15	5.71	1.63	2.72	3.26
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	1187.66	151.14	32.16	4.29	0.54	5.36	4.29
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	690.39	89.66	26.90	8.97	0.00	1.79	7.17
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	452.26	79.73	33.75	2.23	0.74	1.30	6.49
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	341.61	55.45	29.89	2.38	0.43	0.43	3.25
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	265.84	51.70	23.75	1.68	0.63	0.63	6.09
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	903.52	160.28	35.39	4.04	2.02	1.52	6.57
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	862.60	148.61	33.79	4.33	0.87	3.90	4.33
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	660.70	98.49	28.76	6.97	0.00	3.05	5.67
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	822.97	143.51	45.53	4.45	0.49	0.49	5.94
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	896.41	121.86	44.31	2.77	1.85	1.85	2.77
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	790.04	156.33	41.87	5.58	0.00	2.79	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	864.57	102.74	42.09	5.54	0.83	2.22	6.37
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	917.52	115.58	48.83	3.44	0.98	1.96	6.63
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	765.38	149.38	47.74	6.16	0.00	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	734.14	114.60	34.74	4.66	1.07	2.51	3.94
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	745.13	150.96	38.78	2.77	4.15	2.77	1.38
CD8+ T Cells, donor1	11226-116C2	384.04	140.45	15.06	3.60	0.98	0.33	1.64
CD8+ T Cells, donor2	11307-117C2	328.50	120.89	10.14	10.89	1.50	4.13	1.88
CD8+ T Cells, donor3	11383-118B6	410.80	152.76	18.43	5.81	3.03	4.29	2.78
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	203.47	99.56	26.15	1.84	0.23	0.92	3.67
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	185.96	95.62	22.77	0.96	0.00	1.20	2.88
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	217.78	114.09	23.26	1.09	0.27	0.55	4.10
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	341.04	139.30	22.22	1.50	0.60	0.60	1.80
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	183.11	97.19	24.96	1.44	0.00	1.44	4.80
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	214.20	98.46	21.37	1.59	0.23	1.14	3.18
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	234.67	128.63	17.60	1.52	0.22	1.52	6.08
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	219.78	120.81	16.32	1.05	0.26	0.79	5.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	210.83	107.88	16.42	0.23	0.23	0.47	4.22
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	229.43	120.45	25.66	2.72	0.91	0.60	7.85
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	226.01	117.94	28.47	0.87	0.58	0.58	10.17
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	224.07	122.56	20.25	1.87	0.53	0.00	7.99
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	131.76	59.53	12.69	0.88	0.00	0.88	3.06
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	153.02	68.31	12.75	0.46	0.00	1.37	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	127.54	46.99	10.44	0.00	0.00	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	218.97	104.45	24.85	1.44	0.00	1.08	3.60
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	210.90	94.08	25.61	0.86	0.29	0.86	2.59
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	201.76	104.18	22.16	0.94	0.24	0.47	3.06
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	232.61	130.56	15.53	0.95	0.63	0.32	4.75
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	202.38	118.72	13.53	0.62	0.31	1.23	4.61
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	196.52	101.95	10.26	0.96	0.32	0.32	2.89
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	212.27	112.44	21.04	1.91	0.00	1.15	7.27
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	193.90	95.37	18.52	0.39	0.39	0.79	6.70
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	186.08	108.92	21.94	2.27	0.00	0.00	5.29
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	143.73	93.95	23.29	0.80	0.80	0.00	4.82
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	153.17	102.82	18.88	0.70	0.00	0.70	2.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	118.21	122.21	16.03	1.00	0.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	102.35	84.08	7.31	1.83	0.00	3.66	3.66
Cardiac Myocyte, donor2	11605-120I3	184.79	114.63	29.65	0.49	0.00	0.00	2.96
Cardiac Myocyte, donor3	11686-122I3	226.04	117.86	29.57	0.42	2.32	0.21	5.79
Chondrocyte - de diff, donor1	11261-116G1	178.53	89.09	20.11	1.73	0.69	0.69	3.12
Chondrocyte - de diff, donor2	11338-117F6	116.21	52.60	14.57	0.71	0.00	0.00	2.13
Chondrocyte - de diff, donor3	11410-118E6	189.56	118.44	34.82	3.07	0.34	0.91	3.30
Chondrocyte - re diff, donor2	11339-117F7	151.30	71.62	24.17	0.00	2.69	0.90	0.90
Chondrocyte - re diff, donor3	11411-118E7	118.89	47.72	25.48	0.81	0.81	2.43	1.62
Ciliary Epithelial Cells, donor1	11242-116D9	250.40	153.32	41.66	2.18	4.59	0.46	7.80
Ciliary Epithelial Cells, donor2	11323-117D9	188.76	123.77	43.82	3.63	4.49	1.71	7.91
Ciliary Epithelial Cells, donor3	11399-118D4	178.94	113.19	43.89	1.95	4.07	1.06	8.32
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	107.29	48.88	11.00	0.37	1.47	0.09	3.85
Corneal Epithelial Cells, donor1	11526-119I5	44.57	47.43	5.05	0.22	1.32	0.00	0.88
Corneal Epithelial Cells, donor2	11606-120I4	72.81	96.70	3.41	0.00	0.00	0.00	2.28
Corneal Epithelial Cells, donor3	11687-122I4	78.22	75.41	10.74	0.26	2.05	0.26	2.56
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	125.14	43.92	17.83	1.49	0.00	0.33	4.29
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	140.67	40.69	18.92	1.26	0.00	0.00	5.36
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	165.63	44.86	10.35	3.45	0.00	3.45	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	113.61	37.47	15.23	1.73	0.22	0.65	3.02
Dendritic Cells - plasmacytoid, donor1	11228-116C4	444.48	216.60	26.65	3.42	0.68	0.68	4.10
Dendritic Cells - plasmacytoid, donor2	11309-117C4	687.47	300.97	43.74	2.61	1.31	1.96	8.49
Dendritic Cells - plasmacytoid, donor3	11385-118B8	629.13	221.65	35.33	3.39	1.45	2.90	6.29
Endothelial Cells - Aortic, donor0	11207-116A1	111.07	80.05	14.01	0.33	1.17	0.67	3.00
Endothelial Cells - Aortic, donor1	11263-116G3	144.93	59.85	11.74	0.59	0.00	0.00	5.28
Endothelial Cells - Aortic, donor2	11340-117F8	88.52	37.89	17.53	0.00	0.28	0.00	4.52
Endothelial Cells - Aortic, donor3	11412-118E8	108.13	64.09	19.27	1.18	1.97	0.00	5.90
Endothelial Cells - Artery, donor1	11264-116G4	169.00	55.56	12.51	1.16	0.58	0.29	3.20
Endothelial Cells - Artery, donor2	11341-117F9	215.75	119.05	23.76	2.12	0.94	1.41	6.59
Endothelial Cells - Artery, donor3	11413-118E9	140.60	86.25	17.36	0.53	1.05	1.05	5.26
Endothelial Cells - Lymphatic, donor1	11236-116D3	208.80	85.56	23.50	1.55	1.11	0.22	3.99
Endothelial Cells - Lymphatic, donor2	11317-117D3	162.78	82.46	19.47	1.22	0.00	0.00	3.04
Endothelial Cells - Lymphatic, donor3	11393-118C7	151.10	42.57	15.50	0.85	0.28	0.56	2.82
Endothelial Cells - Microvascular, donor1	11265-116G5	101.92	46.95	9.81	0.59	0.30	0.30	2.67
Endothelial Cells - Microvascular, donor2	11342-117G1	111.94	78.10	10.41	1.04	0.52	0.52	4.69
Endothelial Cells - Microvascular, donor3	11414-118F1	78.55	41.26	13.19	1.13	0.28	0.57	1.13
Endothelial Cells - Thoracic, donor1	11266-116G6	244.07	127.24	26.01	0.40	0.80	0.80	8.40
Endothelial Cells - Thoracic, donor2	11343-117G2	111.64	40.88	19.39	1.05	0.52	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	324.03	207.74	43.24	1.49	1.24	1.37	11.31
Endothelial Cells - Umbilical vein, donor2	11324-117E1	239.64	149.04	24.33	0.22	0.65	0.00	6.95
Endothelial Cells - Umbilical vein, donor3	11400-118D5	219.22	149.24	30.41	0.98	1.22	0.24	7.69
Endothelial Cells - Vein, donor1	11267-116G7	123.99	64.84	12.51	0.00	1.14	0.00	3.41
Endothelial Cells - Vein, donor2	11344-117G3	93.60	59.37	10.48	0.00	0.00	0.00	3.49
Endothelial Cells - Vein, donor3	11416-118F3	152.77	73.95	24.34	1.26	1.26	0.31	4.40
Eosinophils, donor1	12244-129H3	335.43	45.74	60.99	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	141.92	85.81	6.60	0.00	1.65	0.00	3.30
Eosinophils, donor3	12246-129H5	128.41	57.07	0.00	0.00	0.00	0.00	7.13
Esophageal Epithelial Cells, donor1	11507-119G4	60.35	71.83	7.57	0.49	0.24	0.00	1.22
Esophageal Epithelial Cells, donor2	11587-120G3	56.16	29.12	2.08	0.00	0.00	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	146.42	65.08	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	169.13	60.35	18.47	1.64	0.82	0.82	2.05
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	139.49	115.62	10.07	2.96	1.20	2.52	2.96
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	203.46	108.45	36.73	2.17	2.28	0.76	5.63
Fibroblast - Aortic Adventitial, donor1	11245-116E3	197.44	135.11	34.20	1.09	1.58	0.00	8.37
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	115.05	129.37	4.78	0.68	1.23	0.00	2.32
Fibroblast - Aortic Adventitial, donor2	11326-117E3	162.42	104.20	24.05	3.59	1.79	0.53	3.48
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	88.80	48.48	11.59	0.53	1.58	1.05	1.58
Fibroblast - Aortic Adventitial, donor3	11401-118D6	192.34	95.01	27.24	1.66	3.65	1.00	4.98
Fibroblast - Cardiac, donor1	11268-116G8	186.89	62.15	16.33	1.36	3.18	1.36	4.99
Fibroblast - Cardiac, donor2	11345-117G4	110.66	65.18	19.71	0.00	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	116.55	77.44	14.83	1.58	1.42	0.32	4.73
Fibroblast - Cardiac, donor4	11452-119A3	153.07	98.21	28.19	0.61	2.12	0.00	3.64
Fibroblast - Cardiac, donor5	11456-119A7	273.99	106.22	27.67	1.27	1.14	0.51	3.30
Fibroblast - Cardiac, donor6	11460-119B2	247.10	94.59	24.10	1.67	1.06	0.45	5.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	106.66	37.25	16.88	0.67	1.21	0.13	2.81
Fibroblast - Choroid Plexus, donor2	11572-120E6	181.20	54.79	26.32	1.29	0.43	0.86	3.88
Fibroblast - Choroid Plexus, donor3	11653-122E6	186.03	130.37	33.69	4.39	2.93	0.00	4.39
Fibroblast - Conjunctival, donor1	11531-120A1	81.65	94.79	8.53	0.00	3.46	0.23	1.85
Fibroblast - Conjunctival, donor3	11692-122I9	351.42	242.87	66.65	1.53	2.20	0.85	4.07
Fibroblast - Dermal, donor1	11269-116G9	304.98	240.42	16.43	1.88	0.70	0.94	3.52
Fibroblast - Dermal, donor2	11346-117G5	151.88	152.82	15.09	0.47	0.47	0.00	4.25
Fibroblast - Dermal, donor3	11418-118F5	277.19	236.21	24.18	2.66	1.09	0.97	3.38
Fibroblast - Dermal, donor4	11450-119A1	281.14	192.52	25.66	2.94	0.57	0.68	5.65
Fibroblast - Dermal, donor5	11454-119A5	371.06	200.97	27.74	2.79	0.70	1.22	8.37
Fibroblast - Dermal, donor6	11458-119A9	368.38	213.26	38.01	2.60	0.97	0.97	10.88
Fibroblast - Gingival, donor1	11237-116D4	236.13	213.02	32.90	0.62	1.25	0.21	3.33
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	176.33	100.61	27.25	1.31	1.31	0.26	8.91
Fibroblast - Gingival, donor2	11318-117D4	237.34	166.05	34.79	2.37	2.64	1.71	5.93
Fibroblast - Gingival, donor3	11394-118C8	212.32	172.88	32.39	1.26	1.45	0.77	3.38
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	146.48	84.15	22.86	3.12	1.04	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	115.77	56.74	20.62	2.11	0.53	0.70	3.17
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	191.28	133.76	31.02	1.71	2.34	0.62	8.26
Fibroblast - Gingival, donor6 (control)	11922-125H5	196.49	128.47	30.83	1.35	0.54	0.95	7.71
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	41.99	33.88	9.88	0.00	1.76	0.00	1.76
Fibroblast - Gingival, donor7 (control)	11924-125H7	167.16	113.78	29.25	1.90	0.73	0.73	6.58
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	179.30	118.22	28.77	1.64	1.77	0.68	8.32
Fibroblast - Gingival, donor8 (control)	11926-125H9	248.13	160.37	26.66	2.08	0.77	0.33	7.68
Fibroblast - Gingival, donor9 (control)	11927-125I1	169.34	69.26	31.11	1.32	1.32	0.59	1.91
Fibroblast - Lung, donor1	11270-116H1	120.98	55.73	8.16	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	262.62	122.36	25.37	1.49	4.48	0.00	5.97
Fibroblast - Lung, donor3	11419-118F6	252.82	141.61	37.14	2.74	1.69	1.48	5.06
Fibroblast - Lymphatic, donor1	11506-119G3	42.48	51.65	12.50	0.00	0.00	0.00	3.33
Fibroblast - Lymphatic, donor2	11586-120G2	103.50	36.36	9.79	0.00	0.00	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	20.71	19.31	1.96	0.00	0.00	0.28	0.56
Fibroblast - Mammary, donor1	11540-120B1	111.24	102.30	11.37	0.00	1.62	0.00	3.65
Fibroblast - Mammary, donor2	11620-122A9	55.92	47.93	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	71.48	77.43	11.91	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	279.52	210.66	35.69	1.94	1.75	0.19	8.92
Fibroblast - Periodontal Ligament, donor2	11319-117D5	243.30	170.19	39.59	0.76	3.03	0.46	6.67
Fibroblast - Periodontal Ligament, donor3	11395-118C9	168.60	158.81	21.73	0.92	1.22	0.31	4.59
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	154.56	66.78	19.84	0.76	0.76	0.00	4.96
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	174.14	103.68	26.46	2.16	2.16	1.08	5.67
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	122.47	57.41	24.24	0.81	0.81	0.35	4.99
Fibroblast - Pulmonary Artery, donor1	11250-116E8	234.77	153.64	31.39	1.44	2.54	0.77	9.73
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	79.24	52.63	8.13	0.00	1.42	0.20	2.84
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	79.52	51.45	8.69	2.00	0.67	0.00	2.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	244.73	171.19	30.44	1.58	1.58	0.40	2.37
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	84.14	54.57	9.53	0.79	0.60	0.20	2.38
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	230.55	90.23	30.55	1.24	0.18	0.89	2.66
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	255.03	119.24	38.63	1.77	1.77	0.39	5.12
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	113.72	46.93	8.72	1.20	0.00	0.60	3.01
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	238.25	102.01	33.57	1.30	0.65	0.76	6.69
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	96.42	56.18	11.89	1.27	0.76	0.51	2.78
Fibroblast - skin normal, donor1	11553-120C5	182.95	91.23	27.24	1.31	1.15	0.66	4.43
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	106.27	96.44	9.02	0.80	1.80	0.40	3.61
Fibroblast - skin normal, donor2	11561-120D4	201.13	100.16	27.23	1.61	0.60	1.00	9.85
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	118.48	68.61	13.00	0.30	1.51	1.51	4.23
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	221.86	111.68	45.40	1.33	0.83	0.41	4.97
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	341.39	120.52	49.23	2.56	0.85	1.03	4.10
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	83.75	31.53	8.54	1.97	0.66	0.00	3.61
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	187.90	91.50	26.95	1.28	1.17	0.32	11.82
Fibroblast - skin walker warburg, donor1	11554-120C6	153.67	80.12	23.11	0.84	1.86	0.34	5.06
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	335.59	122.48	36.85	3.61	1.10	2.04	8.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	1817.10	1174.47	66.48	22.16	0.00	0.00	44.32
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	338.15	108.94	22.66	7.84	0.00	1.74	9.59
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	165.73	126.72	23.06	1.04	0.69	0.52	5.89
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	165.25	144.43	21.86	0.78	0.78	0.52	9.11
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	142.83	120.35	17.12	1.02	1.53	0.77	8.18
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	264.88	173.78	67.37	2.30	9.19	1.53	27.56
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	369.44	217.58	84.23	6.38	7.02	1.28	36.37
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	430.46	282.13	85.29	10.27	5.71	2.28	32.52
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	348.28	230.53	36.40	7.45	0.83	1.93	5.52
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	214.17	134.94	29.00	4.11	3.20	0.68	9.82
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	281.54	183.86	51.12	6.14	4.16	0.79	16.25
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	318.26	212.79	29.87	10.04	2.11	3.44	7.67
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	195.36	89.69	22.18	2.94	1.96	0.98	4.89
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	341.40	229.96	57.93	6.19	5.75	1.77	23.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	468.20	299.04	47.06	5.51	4.52	1.98	12.15
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	322.88	193.33	30.17	4.31	2.22	2.09	8.50
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	345.18	268.36	69.31	4.84	5.37	1.34	24.44
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	269.22	141.73	26.64	3.72	0.87	0.99	5.08
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	330.01	196.98	26.16	3.60	1.38	1.80	6.09
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	305.77	236.24	40.66	5.08	2.24	3.46	16.87
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	221.11	133.71	39.47	1.14	0.91	0.46	8.21
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	285.38	160.81	24.29	3.36	1.37	1.37	3.24
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	246.12	195.63	31.69	1.75	3.28	0.87	6.78
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	296.96	140.94	43.44	1.77	1.18	0.59	5.61
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	290.73	124.62	31.47	4.13	1.11	2.38	5.25
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	248.44	186.11	44.24	2.01	1.56	0.67	9.38
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	251.84	103.44	33.47	3.02	1.21	1.41	6.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	292.80	107.38	24.77	3.05	1.36	1.70	6.62
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	275.33	181.51	44.69	1.33	1.86	0.62	11.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	355.77	167.22	47.24	1.77	1.25	0.83	6.76
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	374.68	145.67	47.65	0.68	1.37	0.34	4.78
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	333.40	115.85	28.33	2.99	1.22	1.00	3.76
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	288.77	158.90	39.77	1.08	1.66	0.42	8.74
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	302.80	140.48	42.47	1.02	2.45	0.82	8.78
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	316.68	108.31	36.31	2.27	1.65	1.03	5.16
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	310.60	111.60	26.29	2.88	0.69	0.81	2.88
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	235.31	107.73	29.52	2.50	1.00	0.33	6.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	245.78	110.88	33.29	1.76	0.66	1.10	3.31
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	396.16	148.82	25.09	4.67	1.11	1.72	3.69
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	253.51	109.90	28.37	3.24	1.95	0.32	8.43
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	323.60	160.68	38.81	0.64	0.64	0.32	5.13
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	258.87	93.05	23.40	3.70	0.95	1.14	2.75
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	206.10	104.40	26.42	1.11	0.63	0.47	5.54
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	227.46	108.26	22.81	3.04	1.52	1.52	6.39
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	234.38	85.62	16.20	1.88	0.52	0.94	3.45
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	239.10	112.19	29.42	1.54	0.66	0.22	4.61
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	188.53	83.88	27.77	2.24	1.12	1.40	6.45
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	159.90	70.46	15.00	2.87	1.20	0.74	4.54
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	189.32	114.18	28.34	2.14	1.87	0.27	6.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	138.01	75.89	24.94	2.30	1.84	1.22	8.11
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	193.66	81.61	14.77	2.46	1.30	0.91	4.79
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	209.27	117.10	34.16	2.71	2.44	0.27	4.88
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	183.06	77.80	30.42	1.47	1.11	0.74	5.90
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	187.95	90.14	30.48	2.85	1.97	0.66	5.26
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	178.51	78.35	26.78	0.99	0.00	0.99	3.97
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	149.72	61.08	28.23	0.26	1.45	0.13	5.67
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	155.76	69.00	25.62	1.21	2.02	0.20	5.45
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	134.45	63.03	34.82	0.51	0.51	0.25	4.07
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	495.86	275.70	73.25	3.58	2.79	1.99	33.64
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	404.30	258.23	38.98	4.78	3.39	2.47	13.25
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	479.34	253.27	45.01	1.84	5.52	1.02	19.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	327.95	189.32	67.59	2.19	3.44	0.63	26.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	318.72	193.55	63.57	1.98	4.24	0.85	32.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	288.71	188.17	59.03	2.77	4.61	2.31	18.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	433.09	240.06	54.45	14.85	0.00	2.47	19.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	369.40	169.04	67.30	7.35	5.03	0.77	27.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	266.34	189.33	62.57	1.60	1.60	3.21	44.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	351.24	139.11	41.73	1.74	1.74	5.22	31.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	337.85	148.42	59.24	2.28	2.93	1.63	18.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	344.27	182.43	62.18	5.77	4.94	1.65	27.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	369.88	153.28	46.65	23.33	3.33	10.00	19.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	324.95	132.55	55.65	3.64	1.40	1.12	15.10
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	313.44	133.68	51.97	2.61	1.31	1.63	21.90
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	349.79	123.31	28.52	16.78	1.68	3.36	10.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	318.07	149.81	55.34	1.59	1.27	0.95	11.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	334.57	135.53	50.27	2.38	1.36	0.34	16.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	620.18	196.29	48.03	8.35	4.18	2.09	12.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	425.52	178.68	64.14	1.15	0.57	2.29	10.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	226.13	116.91	37.00	2.96	0.89	0.59	7.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	491.30	149.08	35.58	8.47	3.39	6.78	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	368.23	132.13	47.63	6.63	2.07	3.73	12.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	329.54	131.17	45.57	2.30	2.76	0.92	10.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	437.28	126.44	57.95	21.07	0.00	5.27	15.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	292.15	111.48	47.28	2.31	3.84	0.38	12.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	299.24	130.06	47.59	2.61	1.96	1.30	7.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	453.47	160.52	48.83	9.36	0.67	1.34	14.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	417.25	184.54	70.50	5.39	2.70	1.54	10.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	395.74	153.03	43.82	2.74	5.82	1.37	13.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	459.69	216.18	49.70	19.88	0.00	4.97	7.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	505.35	242.06	51.43	5.19	0.94	0.94	5.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	365.11	144.23	57.33	4.22	0.60	0.60	5.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	566.16	188.72	48.32	7.63	1.53	3.05	10.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	469.83	158.34	55.04	5.18	2.39	1.20	11.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	548.12	201.78	65.62	6.91	0.99	1.97	5.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	564.25	336.43	48.40	7.08	0.00	3.54	3.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	437.58	187.29	71.76	5.25	1.17	4.67	2.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	470.04	264.65	49.59	4.83	0.88	4.39	4.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	340.77	157.67	43.23	2.54	1.70	0.00	5.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	266.82	94.91	32.83	1.79	1.79	1.19	9.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	277.56	103.84	33.97	4.37	2.43	0.00	5.82
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	101.58	43.37	11.41	3.42	0.00	0.00	2.28
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	111.02	56.97	21.62	2.49	0.83	1.66	3.33
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	68.59	93.33	19.12	0.00	1.12	0.00	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	202.35	153.82	33.30	2.85	0.00	0.63	5.07
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	196.76	180.05	27.15	1.25	0.42	1.67	2.51
Hep-2 cells mock treated, biol_rep1	11898-125E8	336.06	206.90	22.98	2.79	1.74	2.20	8.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	288.99	178.09	21.44	2.70	2.70	1.35	7.93
Hep-2 cells mock treated, biol_rep3	11900-125F1	288.70	180.87	19.57	1.82	1.59	1.37	8.42
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	340.28	215.56	27.33	3.94	1.42	2.19	10.49
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	315.28	166.13	20.85	2.58	1.07	1.07	8.38
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	309.36	162.75	19.81	1.51	1.94	0.86	7.32
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	362.78	215.20	23.54	4.23	1.87	1.25	8.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	325.43	183.73	23.16	2.40	1.89	1.20	6.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	318.45	159.87	23.71	2.24	0.96	1.60	5.13
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	83.94	34.14	13.99	0.56	0.00	0.00	2.80
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	33.33	23.80	6.92	0.43	0.87	0.00	1.73
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	103.11	68.74	23.79	5.29	0.00	0.00	5.29
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	58.20	37.74	10.23	0.00	0.71	0.00	1.06
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	58.12	33.42	3.63	0.00	0.00	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	159.63	101.93	28.50	1.92	1.57	0.70	8.39
Hepatocyte, donor1	11523-119I2	133.17	72.64	8.47	1.21	0.00	0.00	3.63
Hepatocyte, donor2	11603-120I1	201.46	80.80	18.31	1.08	0.00	1.08	3.23
Hepatocyte, donor3	11684-122I1	145.41	61.35	11.66	0.00	0.00	0.61	2.45
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	265.64	72.45	65.27	2.61	0.00	1.96	20.89
Intestinal epithelial cells (polarized), donor1	11246-116E4	239.63	94.73	32.16	1.57	2.45	1.05	9.96
Iris Pigment Epithelial Cells, donor1	11530-119I9	255.89	173.29	26.89	0.82	2.74	0.14	7.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	92.33	73.23	12.74	0.00	0.00	0.00	6.37
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	113.48	106.80	0.00	0.00	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	189.58	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	94.14	62.30	1.38	1.38	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	80.09	77.58	7.51	0.00	5.01	0.00	5.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	35.60	166.16	0.00	0.00	11.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	69.20	51.26	10.25	0.00	2.56	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	91.42	77.70	4.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	102.33	110.45	9.75	0.00	1.62	1.62	3.25
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	91.70	83.37	1.67	3.33	0.00	0.00	3.33
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	108.92	79.87	3.63	0.00	0.00	0.00	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	64.85	82.06	2.65	0.00	1.32	0.00	5.29
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	113.08	93.13	6.65	0.00	2.22	0.00	5.54
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	104.77	110.00	5.24	0.00	0.00	0.00	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	110.86	110.86	6.30	1.26	3.15	0.63	1.89
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	95.89	89.70	9.28	0.00	0.00	1.55	3.09
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	190.25	87.81	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	103.37	105.30	5.17	0.00	2.58	0.00	3.88
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	66.01	77.28	3.22	0.00	1.61	0.00	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	119.48	71.69	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	103.49	111.64	2.44	0.00	1.63	1.63	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	71.79	105.37	5.04	0.84	1.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	100.61	71.86	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	110.10	122.96	4.02	2.41	0.00	0.80	2.41
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	107.10	74.79	5.54	0.00	1.85	0.00	2.77
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	165.89	60.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	101.02	113.29	4.72	0.47	1.89	0.47	1.89
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	86.16	93.42	7.26	3.63	0.00	0.00	2.72
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	88.45	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	103.31	91.47	6.46	0.00	2.15	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	118.15	99.10	3.81	0.00	0.00	0.00	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	65.72	82.15	0.00	0.00	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	75.88	87.36	3.83	1.91	0.64	0.64	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	61.97	91.13	5.47	0.00	1.82	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	126.43	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	96.40	125.68	3.57	2.14	1.43	0.71	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	66.37	46.46	6.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	83.39	83.39	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	126.86	125.01	4.63	0.62	0.93	0.62	1.54
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	100.09	94.83	1.76	0.00	1.76	1.76	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	128.87	132.01	0.00	0.00	0.00	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	78.58	74.41	3.48	0.70	2.09	0.70	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	68.61	70.82	11.07	0.00	2.21	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	100.50	77.81	12.97	0.00	0.00	0.00	6.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	75.86	79.35	3.49	0.87	0.87	0.87	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	96.74	103.49	2.25	0.00	2.25	0.00	4.50
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	121.96	76.66	6.97	0.00	0.00	0.00	10.45
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	89.61	109.88	6.40	1.07	0.00	1.07	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	76.20	81.74	8.31	1.39	0.00	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	74.09	39.89	2.85	0.00	5.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	60.75	78.24	2.76	0.00	0.92	0.00	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	151.27	93.78	3.03	0.00	0.00	0.00	6.05
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	99.34	93.13	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	81.42	95.16	2.11	0.00	0.00	1.06	1.06
Keratinocyte - epidermal, donor1	11272-116H3	134.72	182.29	17.05	0.82	1.47	0.57	5.96
Keratinocyte - epidermal, donor2	11349-117G8	92.53	110.10	6.44	1.76	1.17	0.59	0.59
Keratinocyte - epidermal, donor3	11421-118F8	237.87	159.12	27.73	2.84	1.99	1.42	4.83
Keratinocyte - oral, donor1	11251-116E9	296.05	406.39	40.87	2.38	2.84	0.79	4.99
Keratocytes, donor1	11527-119I6	139.25	119.65	12.38	0.34	4.81	0.00	3.44
Keratocytes, donor2	11607-120I5	59.76	69.14	10.55	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	262.41	198.59	29.84	1.78	1.78	0.79	2.96
Krukenberg tumor cell line:HSKTC	10687-109F3	136.27	52.75	4.40	0.00	0.00	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	195.25	103.56	29.13	2.16	2.16	0.00	8.63
Lens Epithelial Cells, donor2	11609-120I7	229.97	119.48	36.91	0.92	1.96	0.69	4.50
Lens Epithelial Cells, donor3	11690-122I7	165.79	130.07	26.74	0.50	3.03	0.50	5.05
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	138.97	83.12	22.41	0.83	0.83	0.59	2.49
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	129.49	66.70	19.81	1.12	0.84	0.28	5.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	223.21	85.16	28.18	3.15	0.31	2.83	2.99
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	138.73	65.60	19.90	0.54	0.00	0.54	1.61
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	88.88	63.66	22.38	1.26	0.00	0.63	3.15
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	98.97	47.76	16.93	1.08	0.32	0.43	2.37
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	169.49	69.77	24.62	0.41	0.41	1.23	4.10
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	56.63	40.20	13.65	0.51	1.01	0.00	2.78
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	101.48	51.09	16.75	1.27	0.70	0.99	2.82
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	188.27	79.11	20.17	0.00	0.00	0.40	3.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	157.43	81.24	22.88	1.55	0.97	1.16	3.10
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	44.25	23.51	7.59	1.11	0.00	0.00	0.93
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	179.79	76.30	20.56	1.05	0.35	0.70	5.23
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	117.12	59.39	20.75	0.95	0.24	0.48	2.39
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	92.71	48.21	15.93	0.69	0.27	0.69	3.02
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	166.61	84.07	13.24	0.62	0.31	1.85	1.85
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	73.57	49.26	12.47	1.56	0.62	0.00	3.12
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	92.23	47.76	14.64	0.73	0.55	0.73	1.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	169.16	68.46	20.08	1.97	0.00	0.66	2.96
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	72.63	35.14	12.89	1.46	0.59	0.59	3.81
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	62.73	34.35	14.19	0.00	0.00	0.25	2.99
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	202.71	70.32	24.25	1.94	0.00	0.00	6.30
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	175.04	89.41	19.12	1.08	0.27	1.35	5.12
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	138.96	57.67	17.56	0.91	0.45	0.61	3.18
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	137.38	68.95	22.29	1.56	0.52	0.00	5.70
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	177.98	101.35	23.45	3.14	0.63	1.68	2.93
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	99.55	43.16	12.48	0.45	0.30	0.75	3.31
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	168.53	78.42	23.39	0.69	0.00	0.00	4.82
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	146.76	81.09	17.87	0.19	0.19	0.38	1.88
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	70.93	38.59	11.88	0.74	0.32	0.32	1.59
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	169.60	63.96	19.38	0.97	0.00	0.97	1.94
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	122.06	72.44	16.87	1.32	0.33	0.00	2.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	74.71	45.84	12.27	1.12	0.50	0.62	1.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	192.88	83.30	18.88	0.37	0.74	1.11	4.44
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	154.67	83.51	20.51	0.74	0.99	0.99	2.47
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	77.27	40.15	10.59	0.41	0.55	0.55	1.10
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	180.12	78.16	22.84	0.96	1.29	0.64	2.25
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	200.25	103.78	25.87	1.22	0.91	1.52	2.43
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	168.24	69.70	20.02	1.40	0.28	1.26	2.38
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	173.16	76.09	19.91	0.71	0.71	0.00	2.84
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	90.65	52.36	14.06	1.45	0.00	0.00	1.45
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	48.24	29.57	7.94	0.62	0.16	0.47	1.56
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	161.86	59.80	15.04	1.07	0.00	1.43	3.22
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	135.24	70.56	13.72	0.33	0.33	0.00	1.63
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	55.32	32.02	8.71	0.24	0.00	0.24	1.18
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	132.29	77.59	19.55	0.99	0.99	0.37	2.35
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	76.58	46.36	12.04	0.77	0.51	1.54	1.54
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	136.95	39.68	14.62	0.60	0.60	0.90	1.79
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	97.44	54.38	20.39	0.00	11.33	0.00	15.86
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	153.43	41.43	19.18	1.53	3.84	0.00	8.44
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	135.09	34.88	27.46	1.48	0.74	0.00	13.36
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	117.63	56.70	26.66	2.96	2.12	0.85	9.73
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	146.99	35.87	26.73	3.52	2.11	0.70	2.11
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	158.77	42.03	34.56	1.87	1.87	0.00	10.27
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	127.27	50.50	32.46	6.70	2.58	2.06	12.88
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	157.01	33.30	14.27	4.76	1.19	0.00	9.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	141.82	68.76	23.07	0.45	2.26	0.00	10.63
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	163.15	72.13	41.59	4.07	3.20	0.29	9.89
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	204.83	61.67	37.81	7.20	2.25	0.45	9.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	146.46	72.21	31.30	0.95	2.57	0.41	14.77
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	124.79	46.22	25.16	2.57	1.54	0.51	10.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	201.48	56.10	29.29	1.76	2.12	0.35	9.17
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	222.55	43.31	49.97	1.33	1.33	0.67	15.99
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	112.57	52.98	28.02	3.57	3.57	0.51	8.15
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	168.09	58.43	34.42	3.47	2.13	1.33	12.54
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	168.54	70.48	46.67	4.91	3.59	0.57	16.06
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	103.08	49.09	28.22	2.45	3.68	0.61	8.59
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	146.78	60.34	28.54	8.15	3.26	0.82	4.89
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	174.92	71.84	39.57	4.16	2.71	1.04	11.87
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	151.90	69.78	41.20	2.24	3.64	2.24	14.85
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	120.55	49.46	24.73	1.03	1.03	1.03	8.24
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	169.25	62.13	33.38	4.06	2.32	0.87	9.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	153.05	57.10	37.07	1.20	1.79	1.20	14.95
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	196.41	52.56	34.30	5.53	3.32	2.77	14.38
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	114.18	53.38	27.22	3.53	2.83	2.12	11.31
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	142.72	60.11	33.19	1.48	3.69	1.48	9.96
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	111.67	49.50	33.39	2.30	2.30	1.15	5.76
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	110.52	49.50	32.62	1.15	3.07	0.00	8.06
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	116.06	62.84	26.04	2.83	1.70	1.13	12.45
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	149.33	37.74	28.72	1.64	1.64	0.82	9.85
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	125.62	47.00	24.40	4.52	2.71	0.45	6.78
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	134.29	55.30	28.73	3.59	2.15	2.87	12.21
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	186.73	57.51	32.12	1.49	1.49	1.49	14.19
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	115.57	57.23	31.96	4.46	2.97	0.74	5.95
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	153.78	56.00	31.88	0.86	4.74	0.43	10.34
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	131.87	62.51	31.68	2.57	2.57	0.00	10.28
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	132.27	69.63	32.65	2.00	3.00	2.00	10.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	111.01	62.14	23.53	1.21	0.60	0.60	5.43
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	113.05	39.82	22.04	0.71	0.00	0.00	4.98
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	115.83	50.87	33.34	2.75	1.37	1.03	7.22
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	118.08	52.60	20.40	5.90	1.07	0.00	7.51
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	160.93	47.81	20.20	3.37	2.02	0.67	2.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	138.16	56.67	29.63	1.85	1.48	1.85	8.89
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	101.17	66.29	27.91	1.16	3.49	3.49	18.61
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	135.39	32.79	23.27	1.06	2.12	1.06	5.29
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	114.84	54.02	26.01	3.20	2.80	0.40	5.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	101.04	56.70	26.17	2.18	0.73	1.45	5.81
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	105.01	60.55	16.86	2.30	2.30	0.00	8.43
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	122.83	47.85	33.05	3.45	4.93	1.48	9.87
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	91.27	61.16	26.35	0.94	0.94	0.00	14.11
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	107.60	41.73	21.62	1.01	2.51	0.00	6.54
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	109.95	55.43	26.59	1.80	3.15	0.90	9.91
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	94.66	34.42	22.37	0.00	0.00	0.00	6.88
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	117.57	51.21	25.83	4.01	1.34	0.89	8.91
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	101.67	51.22	26.98	3.52	1.56	0.78	8.99
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	116.77	52.12	23.75	3.30	3.30	1.32	12.53
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	112.09	49.30	25.95	1.56	0.52	0.52	7.26
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	111.14	51.20	23.19	3.94	1.31	1.75	10.94
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	128.03	58.71	25.16	0.00	2.24	0.56	9.50
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	95.84	41.96	20.32	0.88	1.77	0.88	9.27
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	122.66	52.84	23.53	3.09	2.70	0.77	10.03
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	90.64	49.62	24.81	0.51	1.01	1.01	8.10
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	103.81	44.22	26.43	3.84	1.44	0.48	9.13
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	108.13	60.82	34.19	2.39	1.99	1.19	9.94
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	114.23	51.04	24.91	1.82	1.22	1.82	7.90
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	127.27	51.19	17.29	0.69	0.69	0.00	7.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	109.06	57.00	21.28	1.52	3.04	1.52	5.32
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	117.23	48.54	16.53	3.10	1.03	2.07	8.26
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	122.14	40.51	16.93	0.00	0.00	1.21	12.70
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	114.08	60.53	22.50	3.17	2.22	1.27	12.36
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	113.01	48.51	24.52	1.07	3.73	0.00	10.66
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	122.40	39.08	25.29	1.15	2.30	1.15	9.19
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	113.65	64.79	24.68	2.57	1.54	0.51	8.23
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	111.05	54.47	25.46	2.12	0.71	0.00	12.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	134.49	47.67	27.81	2.84	0.00	1.70	8.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	115.24	51.59	16.22	2.50	3.33	1.25	9.15
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	113.54	60.29	23.49	0.78	2.35	0.00	10.18
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	153.24	47.18	27.98	1.67	0.84	0.00	12.11
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	110.12	56.22	21.37	2.79	4.18	1.39	8.36
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	120.43	70.25	28.10	1.34	2.01	1.34	10.70
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	132.06	47.05	21.39	3.21	0.53	1.07	11.76
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	138.60	61.42	28.69	3.23	3.23	2.02	9.70
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	111.05	42.22	24.78	3.67	1.84	0.00	8.26
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	104.03	45.34	29.34	2.67	0.89	0.89	8.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	135.06	55.85	26.21	2.28	2.85	0.00	10.83
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	130.37	39.11	21.47	0.77	0.00	0.77	9.97
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	172.36	48.70	39.94	3.83	1.09	0.00	12.59
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	109.13	52.56	23.16	1.34	2.67	0.89	7.13
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	135.96	54.85	29.11	0.78	2.08	0.26	8.06
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	153.18	47.74	39.12	1.33	1.33	0.00	17.24
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	103.93	41.57	29.10	0.00	4.16	0.00	10.39
Macrophage - monocyte derived, donor1	11232-116C8	127.63	46.27	17.78	1.37	0.91	0.68	5.47
Macrophage - monocyte derived, donor2	11313-117C8	114.69	55.24	14.86	0.18	0.00	0.55	4.59
Macrophage - monocyte derived, donor3	11389-118C3	118.10	50.47	16.25	1.57	0.13	0.79	4.59
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	210.82	194.88	24.43	0.53	1.59	0.00	10.62
Mallassez-derived cells, donor2	11929-125I3	162.73	102.99	20.44	0.63	0.63	1.11	7.92
Mallassez-derived cells, donor3	11930-125I4	252.82	195.97	20.57	0.56	0.83	0.14	7.64
Mammary Epithelial Cell, donor1	11273-116H4	216.92	264.85	28.60	0.80	2.59	0.90	4.68
Mammary Epithelial Cell, donor2	11350-117G9	252.78	210.50	29.82	2.61	1.45	1.45	4.92
Mammary Epithelial Cell, donor3	11422-118F9	101.27	83.31	15.22	0.75	1.00	0.50	3.49
Mast cell - stimulated, donor1	11487-119E2	299.65	100.33	34.57	0.68	0.00	0.00	4.75
Mast cell, donor1	11563-120D6	215.52	58.83	22.17	1.19	0.32	0.54	2.49
Mast cell, donor2	11565-120D8	282.91	106.09	16.05	0.89	0.89	0.00	1.19
Mast cell, donor3	11566-120D9	273.98	152.18	14.86	1.13	0.68	0.68	1.80
Mast cell, donor4	11567-120E1	231.36	91.48	12.41	0.89	0.53	0.18	1.77
Mast cell, expanded and stimulated, donor5	11940-126A5	245.74	64.98	21.74	1.89	0.00	0.55	5.43
Mast cell, expanded and stimulated, donor8	11942-126A7	207.21	77.05	34.44	0.58	0.00	0.58	7.00
Mast cell, expanded, donor5	11939-126A4	222.10	48.53	23.52	1.15	0.11	0.11	4.24
Mast cell, expanded, donor8	11941-126A6	169.38	42.68	27.95	0.50	0.33	0.84	3.51
Melanocyte - dark, donor1	11502-119F8	255.31	113.73	39.70	0.99	0.40	0.50	6.96
Melanocyte - dark, donor2	11582-120F7	187.58	103.82	29.07	1.38	0.35	1.04	5.19
Melanocyte - dark, donor3	11663-122F7	133.58	78.24	25.14	0.43	0.87	0.29	6.52
Melanocyte - light, donor1	11274-116H5	26.56	17.40	7.76	0.00	0.00	0.00	1.88
Melanocyte - light, donor2	11351-117H1	39.58	34.81	6.82	0.00	0.68	0.00	1.36
Melanocyte - light, donor3	11423-118G1	41.63	50.30	8.67	0.87	1.73	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	182.43	77.26	14.99	0.94	1.15	0.52	4.48
Melanocyte, donor2 (MC+2)	12739-135I3	160.56	60.78	19.36	1.61	1.08	0.54	3.77
Melanocyte, donor3 (MC+3)	12837-137B2	175.18	55.71	26.25	0.54	0.54	0.54	4.02
Meningeal Cells, donor1	11493-119E8	141.43	72.08	18.36	0.50	0.74	0.12	6.33
Meningeal Cells, donor2	11573-120E7	158.01	77.03	17.17	0.44	0.44	0.44	2.64
Meningeal Cells, donor3	11654-122E7	272.70	190.80	47.27	0.90	3.02	0.41	13.53
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	285.16	220.71	33.65	0.86	1.14	0.57	9.12
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	222.09	154.47	21.03	1.71	2.01	0.20	3.92
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	38.11	32.85	19.71	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	52.33	35.32	5.23	0.00	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	172.23	161.46	15.07	2.87	1.44	0.72	5.02
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	162.85	84.07	21.39	1.06	1.91	0.42	2.54
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	112.59	64.84	15.58	1.51	2.51	0.00	9.05
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	86.14	77.79	13.19	0.66	1.54	0.00	3.30
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	91.32	72.33	8.77	0.00	1.46	1.46	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	84.30	56.88	9.82	0.41	1.64	0.20	2.86
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	249.87	187.40	42.66	0.69	0.55	0.83	4.02
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	56.13	29.37	7.81	0.37	0.37	0.00	1.49
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	264.20	182.49	38.95	0.92	1.84	0.53	3.55
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	99.11	92.29	11.87	1.48	0.89	0.30	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	49.05	67.73	14.01	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	93.50	101.82	12.17	1.28	1.28	0.64	4.48
Mesenchymal stem cells - adipose, donor0	11217-116B2	245.28	220.82	15.24	1.06	1.42	0.35	6.03
Mesenchymal stem cells - hepatic, donor0	11218-116B3	277.07	165.12	27.21	1.25	0.94	0.00	3.44
Mesenchymal stem cells - umbilical, donor0	11214-116A8	301.16	214.80	40.64	0.73	2.90	0.73	15.24
Mesothelial Cells, donor1	11247-116E5	159.37	80.61	14.32	0.53	1.06	0.00	5.57
Mesothelial Cells, donor2	12156-128G5	120.61	95.09	9.51	2.00	2.50	1.00	5.51
Mesothelial Cells, donor3	11402-118D7	88.02	46.25	12.72	2.75	1.88	0.51	3.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	58.06	31.06	13.50	0.00	1.35	0.00	5.40
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	197.76	64.28	13.55	2.22	0.00	0.99	2.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	140.16	95.40	18.26	0.29	0.29	0.29	2.94
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	24.20	27.66	6.91	0.00	0.00	0.00	6.91
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	198.68	65.71	9.92	3.10	0.00	0.00	5.27
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	122.18	62.44	10.58	0.83	0.41	0.41	2.28
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	32.42	23.16	2.32	0.00	0.00	0.00	13.90
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	178.94	57.81	11.51	1.00	0.25	0.75	5.76
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	107.06	79.60	11.64	0.00	0.47	0.00	3.72
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	146.92	48.37	13.62	1.02	0.00	0.61	4.27
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	111.27	66.92	10.69	2.77	0.00	0.40	6.73
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	8.55	0.00	0.00	17.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	161.94	42.48	10.62	2.65	0.88	1.77	5.31
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	158.43	85.11	15.20	2.28	0.38	1.14	6.08
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	38.16	28.95	7.90	0.00	0.00	0.00	3.95
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	141.55	45.20	10.61	1.49	0.00	1.27	3.82
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	58.93	40.52	7.37	0.00	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	83.46	33.98	11.03	1.19	0.00	1.49	1.49
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	102.28	67.07	8.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	132.98	44.41	12.04	2.01	0.00	0.25	3.26
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	98.87	58.23	8.32	1.43	0.48	0.71	3.33
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	59.71	19.35	5.53	0.00	0.00	0.00	4.42
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	111.90	34.31	14.74	2.76	0.00	0.92	2.53
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	107.27	62.89	11.15	0.42	0.21	0.63	4.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	104.36	39.95	8.97	0.61	0.00	0.00	3.06
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	134.95	52.56	12.66	1.07	0.00	0.21	2.57
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	82.03	51.35	8.67	0.22	0.22	0.00	2.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	20.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	80.82	29.79	9.86	1.10	0.22	0.44	3.50
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	47.65	42.08	6.59	0.51	0.00	0.00	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	38.11	18.23	3.31	0.00	0.00	0.00	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	106.00	31.53	8.43	0.82	0.00	0.82	2.72
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	91.75	56.76	8.53	0.29	0.29	0.00	2.06
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	28.35	15.26	7.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	95.63	31.72	9.61	0.96	0.48	0.00	3.84
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	82.45	54.83	6.40	0.40	0.40	0.40	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	56.22	28.80	4.11	0.00	0.00	0.00	2.74
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	79.09	34.04	12.01	0.50	0.00	0.00	4.51
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	161.68	53.89	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	28.54	22.42	0.00	0.00	0.00	0.00	2.04
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	97.66	45.98	7.44	0.88	0.44	0.44	3.07
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	41.94	29.80	1.10	0.00	0.00	0.00	2.21
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	37.78	20.49	1.28	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	106.61	45.62	8.68	0.99	0.00	0.25	2.48
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	43.15	32.01	4.87	0.70	0.00	0.00	1.39
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	57.46	19.89	2.21	0.00	0.00	0.00	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	97.43	37.61	8.55	1.37	0.00	0.00	2.74
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	56.45	30.63	4.81	0.00	0.00	0.00	1.75
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	55.75	22.37	1.78	0.36	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	99.32	44.89	9.54	0.56	0.28	0.28	3.09
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	69.41	32.00	4.57	0.00	0.00	0.83	3.33
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	43.71	26.22	1.75	0.00	0.58	0.00	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	56.41	27.15	5.73	0.30	0.00	0.00	3.62
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	75.13	50.09	8.35	1.25	0.00	1.67	4.59
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	64.97	7.22	7.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	66.50	31.40	7.39	0.00	0.00	0.00	6.46
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	70.00	43.82	9.68	0.00	0.00	0.00	5.69
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	87.47	30.54	3.59	0.28	0.14	0.41	1.93
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	73.86	36.54	10.88	1.55	0.26	0.00	5.96
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	75.50	44.18	3.43	0.00	0.00	0.00	3.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	33.67	13.97	2.54	0.00	0.00	0.00	2.54
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	55.51	22.95	8.27	0.27	0.00	0.00	3.20
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	97.28	54.78	7.48	0.60	1.20	0.30	2.99
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	59.75	29.38	3.53	0.28	0.57	0.14	1.70
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	74.21	34.72	9.24	0.96	0.32	0.32	6.37
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	104.82	54.40	5.75	1.33	0.00	0.66	4.42
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	69.39	34.13	5.31	0.00	0.00	0.38	3.03
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	84.10	38.35	9.38	0.57	0.57	0.00	5.97
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	101.52	55.06	11.31	0.74	0.49	0.25	4.92
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	46.92	23.46	2.61	0.00	0.00	0.00	2.61
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	76.15	36.17	11.47	0.59	0.00	0.88	4.12
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	118.79	70.64	7.21	0.58	1.15	0.58	3.17
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	98.09	49.46	11.54	0.82	0.41	0.00	2.89
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	86.06	30.97	8.93	0.30	0.00	0.60	6.25
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	173.28	45.20	11.30	3.77	3.77	0.00	7.53
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	163.97	33.86	17.82	5.35	0.00	0.00	3.56
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	157.39	35.49	13.80	3.61	0.00	0.33	6.24
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	151.48	42.08	22.09	3.16	0.00	3.16	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	170.41	52.39	14.63	1.58	0.20	1.19	4.35
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	188.13	50.29	18.63	1.86	0.93	0.00	2.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	203.91	52.57	21.78	4.51	0.00	0.75	3.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	131.31	37.55	14.92	1.86	0.00	0.53	5.06
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	157.10	36.08	13.80	0.68	0.11	0.34	5.54
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	102.40	24.31	9.58	2.21	0.74	0.74	2.95
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	112.13	29.68	12.82	2.20	0.73	0.37	2.20
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	150.89	35.78	9.33	4.67	1.56	3.11	4.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	256.53	59.86	31.00	1.60	1.07	0.53	6.95
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	77.28	38.64	3.86	0.00	0.00	3.86	7.73
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	71.71	22.22	8.08	4.04	0.00	1.01	6.06
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	149.68	47.22	23.61	2.53	0.00	0.84	6.75
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	345.93	73.54	23.15	1.36	0.00	0.00	8.17
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	242.24	77.57	26.07	0.64	0.00	0.64	7.63
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	272.91	80.98	24.30	1.62	0.81	0.00	3.24
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	222.03	63.44	39.27	4.53	0.00	0.00	6.04
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	154.17	17.13	22.84	0.00	0.00	0.00	5.71
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	261.00	110.92	39.15	0.00	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	104.55	42.77	4.75	0.00	0.00	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	112.94	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	188.51	115.47	19.39	0.86	1.51	0.86	5.17
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	220.54	64.28	38.67	1.57	0.00	2.09	6.79
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	92.11	57.40	8.01	0.00	1.33	0.67	2.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	47.16	36.73	2.09	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	167.90	76.44	18.25	1.52	0.95	0.76	6.46
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	276.08	164.37	17.55	0.00	1.60	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	55.08	39.44	5.44	0.00	0.68	0.00	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	374.88	130.47	22.05	1.84	0.00	1.84	23.89
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	77.43	44.78	10.88	0.42	1.26	0.42	1.26
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	112.73	75.08	8.83	1.39	0.70	0.70	1.86
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	169.43	72.42	8.38	1.35	0.81	0.00	1.35
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	110.79	58.66	15.56	1.05	1.26	0.42	4.41
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	656.95	400.85	55.67	11.13	0.00	11.13	22.27
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	126.07	67.50	13.40	0.00	1.99	0.00	1.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	141.56	70.64	20.30	1.35	1.08	0.54	4.60
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	171.60	94.98	9.97	0.68	0.68	0.45	1.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	77.24	41.32	12.41	0.49	0.65	0.00	2.12
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	179.52	71.44	18.04	1.64	1.28	0.73	3.46
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	150.64	79.57	11.67	2.12	0.53	0.00	2.12
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	103.25	52.23	10.21	1.20	0.60	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	258.60	94.84	34.46	2.95	3.61	2.63	7.22
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	94.48	43.75	7.32	1.46	0.49	0.65	1.46
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	156.27	75.14	20.46	0.71	0.71	0.88	2.12
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	139.24	78.76	10.55	2.11	0.00	1.41	2.11
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	123.66	57.00	12.41	1.84	2.76	0.46	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	205.98	76.16	12.85	1.61	3.53	0.00	1.29
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	279.36	114.50	20.69	3.79	2.76	1.38	3.10
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	520.86	121.37	40.46	5.06	2.53	10.11	7.59
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	145.48	57.03	18.05	0.22	1.11	0.00	1.34
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	122.36	51.23	6.35	1.69	0.85	0.00	2.96
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	148.58	50.32	9.97	0.47	1.42	0.47	2.37
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	185.86	54.51	10.73	1.72	1.29	0.00	1.72
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	1065.28	297.92	18.06	9.03	9.03	9.03	18.06
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	164.61	59.98	12.33	0.33	1.67	0.67	1.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	86.11	54.10	15.78	0.90	0.90	0.00	2.71
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	106.74	55.55	8.73	0.00	0.79	0.79	1.59
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	222.87	83.58	11.14	1.86	0.00	0.93	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	218.70	60.92	11.35	1.14	0.76	0.38	1.51
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	106.89	42.37	4.24	0.33	0.33	0.00	1.30
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	115.92	41.84	6.10	0.00	0.00	0.00	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	136.59	61.06	17.19	0.00	1.36	0.00	3.17
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	149.92	76.73	8.82	0.88	1.76	0.00	2.65
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	155.57	54.52	6.65	1.33	1.33	1.33	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	204.37	56.05	10.91	0.99	0.00	0.99	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	85.75	39.05	5.74	0.38	0.38	0.00	1.53
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	231.07	75.91	9.98	2.12	0.60	0.60	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	118.25	51.72	15.91	0.88	1.55	0.22	2.65
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	149.08	55.57	7.45	1.36	0.68	1.36	2.03
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	464.97	163.50	30.66	5.11	5.11	10.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	216.44	51.21	7.93	1.22	1.22	0.00	1.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	95.36	44.38	5.67	0.00	0.63	0.31	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	164.04	54.78	5.15	0.61	0.91	0.00	1.82
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	134.49	45.09	10.28	0.00	0.00	0.00	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	224.46	65.75	27.21	1.13	1.13	1.13	6.80
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	753.63	136.56	35.41	15.17	5.06	20.23	10.12
Myoblast, donor1	11241-116D8	163.24	173.30	14.16	1.12	0.87	0.37	6.83
Myoblast, donor2	11322-117D8	208.86	143.46	25.32	2.49	1.34	1.15	7.48
Myoblast, donor3	11398-118D3	159.59	119.06	16.31	1.35	1.01	0.84	7.40
NK T cell leukemia cell line:KHYG-1	10777-110G3	350.82	68.15	42.32	2.92	0.15	1.17	5.11
Natural Killer Cells, donor1	11230-116C6	356.72	128.23	14.15	2.46	1.54	1.54	0.92
Natural Killer Cells, donor2	11311-117C6	328.70	116.70	17.79	5.73	2.71	1.81	0.90
Natural Killer Cells, donor3	11387-118C1	266.88	113.01	15.09	4.60	0.18	1.66	0.92
Neural stem cells, donor1	11275-116H6	213.77	122.67	41.01	2.18	1.81	0.73	12.34
Neural stem cells, donor2	11352-117H2	279.22	94.36	21.18	1.93	0.00	1.93	3.85
Neurons, donor1	11494-119E9	382.33	88.76	30.72	1.14	1.14	1.14	13.65
Neurons, donor2	11574-120E8	223.69	77.28	20.70	1.10	2.20	0.66	6.38
Neurons, donor3	11655-122E8	337.91	93.73	16.44	4.93	0.82	1.64	8.22
Neutrophils, donor1	11233-116C9	63.10	28.77	2.78	0.93	0.00	0.00	0.93
Neutrophils, donor2	11314-117C9	101.46	23.19	20.29	0.00	0.00	2.90	0.00
Neutrophils, donor3	11390-118C4	95.29	25.04	6.72	0.00	0.00	0.00	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	264.90	184.51	58.06	1.54	1.90	0.36	2.49
Nucleus Pulposus Cell, donor2	11409-118E5	144.24	137.73	39.07	1.95	0.98	0.33	3.91
Nucleus Pulposus Cell, donor3	11462-119B4	362.40	138.38	33.09	1.80	1.00	0.80	3.81
Olfactory epithelial cells, donor1	11933-125I7	137.38	73.09	17.21	2.48	0.96	1.24	1.51
Olfactory epithelial cells, donor2	11934-125I8	180.79	109.28	23.59	2.75	1.16	1.88	4.05
Olfactory epithelial cells, donor3	11935-125I9	171.96	95.68	21.34	1.93	0.45	0.91	2.38
Olfactory epithelial cells, donor4	11936-126A1	183.79	76.94	21.82	1.66	0.88	1.56	3.21
Oligodendrocyte - precursors, donor1	11496-119F2	208.83	151.06	28.29	0.60	1.20	0.00	9.03
Osteoblast - differentiated, donor1	11276-116H7	185.89	100.18	17.44	0.00	1.28	0.00	1.49
Osteoblast - differentiated, donor2	11353-117H3	93.74	70.87	16.00	9.14	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	173.80	103.66	24.83	3.10	1.86	1.24	3.72
Osteoblast, donor1	11277-116H8	140.91	107.10	10.55	0.00	1.56	0.00	3.52
Osteoblast, donor2	11354-117H4	264.77	136.95	25.99	0.70	4.92	0.00	7.73
Osteoblast, donor3	11426-118G4	114.99	76.42	23.99	0.36	2.67	0.36	5.15
Pancreatic stromal cells, donor1	11249-116E7	230.55	152.55	29.99	1.26	2.78	0.59	6.74
Pericytes, donor1	11491-119E6	42.50	32.16	7.45	0.45	0.45	0.22	1.11
Pericytes, donor2	11571-120E5	102.54	35.54	11.32	0.23	0.68	0.23	0.68
Pericytes, donor3	11652-122E5	83.62	50.05	11.19	1.02	0.61	0.81	2.64
Perineurial Cells, donor1	11499-119F5	267.30	156.99	33.91	0.68	0.68	0.11	3.62
Perineurial Cells, donor2	11579-120F4	218.43	176.02	36.99	0.64	1.38	0.09	5.61
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	409.26	132.60	25.18	0.96	1.59	1.27	3.82
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	319.55	98.43	20.08	2.20	0.73	3.18	1.22
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	266.08	74.80	21.09	1.94	0.78	0.39	2.33
Placental Epithelial Cells, donor1	11278-116H9	84.66	43.29	8.61	0.48	1.91	0.24	2.87
Placental Epithelial Cells, donor2	11355-117H5	120.87	43.25	11.09	0.00	1.11	0.00	3.33
Placental Epithelial Cells, donor3	11427-118G5	79.91	38.28	20.61	0.79	1.77	0.79	1.77
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	120.88	47.78	12.66	1.58	1.90	0.63	4.11
Preadipocyte - breast, donor1	11467-119B9	132.81	81.23	21.57	1.69	0.94	0.19	5.63
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	82.36	64.48	5.74	0.26	1.17	0.13	1.17
Preadipocyte - breast, donor2	11328-117E5	129.01	66.87	22.51	2.25	0.23	0.68	3.60
Preadipocyte - omental, donor1	11468-119C1	145.13	86.53	21.95	1.60	1.17	0.32	5.65
Preadipocyte - omental, donor2	11329-117E6	116.54	79.87	13.09	0.44	0.44	0.44	3.49
Preadipocyte - omental, donor3	11403-118D8	99.84	77.93	18.48	1.29	0.86	0.43	3.58
Preadipocyte - perirenal, donor1	11469-119C2	95.47	38.39	9.84	0.98	0.00	0.00	7.87
Preadipocyte - subcutaneous, donor1	11279-116I1	84.76	117.01	11.06	0.92	1.23	0.31	1.23
Preadipocyte - subcutaneous, donor2	11356-117H6	270.40	212.32	36.30	3.72	3.36	1.42	9.56
Preadipocyte - subcutaneous, donor3	11428-118G6	222.22	148.83	30.14	2.55	2.38	1.36	7.32
Preadipocyte - visceral, donor1	11280-116I2	261.37	238.83	32.88	1.49	2.51	0.28	8.76
Preadipocyte - visceral, donor2	11357-117H7	219.51	190.97	32.67	0.92	1.38	0.46	5.06
Preadipocyte - visceral, donor3	11429-118G7	297.59	142.21	26.54	1.78	1.36	1.04	7.52
Prostate Epithelial Cells (polarized), donor1	11253-116F2	214.96	100.62	31.38	1.36	2.26	0.60	10.26
Prostate Epithelial Cells, donor2	11331-117E8	85.45	99.80	10.83	0.81	0.41	0.41	4.87
Prostate Epithelial Cells, donor3	11404-118D9	156.89	169.81	13.96	2.82	2.14	1.47	2.82
Prostate Stromal Cells, donor1	11254-116F3	196.36	208.32	25.06	1.37	4.78	0.46	8.66
Prostate Stromal Cells, donor2	11332-117E9	199.56	167.64	33.17	2.33	2.69	1.61	7.89
Prostate Stromal Cells, donor3	11405-118E1	181.34	142.13	26.59	3.02	2.82	1.25	4.28
Renal Cortical Epithelial Cells, donor1	11516-119H4	67.52	48.91	5.84	0.00	1.09	0.00	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	141.74	144.10	25.44	1.04	0.90	0.55	4.23
Renal Epithelial Cells, donor1	11517-119H5	30.94	26.88	5.58	0.00	1.01	0.00	1.52
Renal Epithelial Cells, donor2	11597-120H4	42.68	32.01	6.40	0.00	0.71	0.00	1.42
Renal Epithelial Cells, donor3	11678-122H4	169.49	179.97	29.64	0.53	2.54	0.74	5.08
Renal Glomerular Endothelial Cells, donor1	11514-119H2	31.32	17.02	5.45	0.00	0.00	0.00	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	120.07	50.54	8.76	0.54	0.13	0.67	3.10
Renal Glomerular Endothelial Cells, donor3	11675-122H1	164.95	90.58	27.75	2.00	1.78	1.55	7.33
Renal Glomerular Endothelial Cells, donor4	11783-124B1	39.93	18.63	2.66	0.00	0.67	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	64.05	49.96	8.14	0.66	0.66	0.00	1.32
Renal Mesangial Cells, donor2	11598-120H5	67.09	44.52	8.15	0.63	1.88	0.63	1.25
Renal Mesangial Cells, donor3	11679-122H5	36.06	32.46	4.44	0.00	0.55	0.28	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	104.68	85.63	13.15	1.07	0.54	0.00	4.03
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	63.68	45.12	5.90	0.42	0.84	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	68.27	55.93	10.61	1.16	1.74	0.96	2.12
Retinal Pigment Epithelial Cells, donor0	11215-116A9	263.69	181.76	26.45	1.04	3.89	0.00	7.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	113.13	77.60	12.79	1.14	1.99	0.28	2.84
Retinal Pigment Epithelial Cells, donor2	11608-120I6	56.60	43.22	7.20	0.00	1.03	0.00	2.06
Retinal Pigment Epithelial Cells, donor3	11689-122I6	258.18	194.96	41.90	0.75	2.01	0.75	5.77
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	257.92	95.02	21.11	1.87	0.27	0.94	7.48
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	174.21	72.37	38.42	0.00	0.00	0.00	8.93
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	466.16	140.34	55.04	1.65	0.55	0.55	13.76
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	278.43	102.09	42.34	0.00	0.00	0.58	15.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	181.26	83.35	27.70	1.04	0.91	0.52	13.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	155.61	73.29	22.24	0.79	1.29	0.79	8.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	199.88	116.34	30.56	0.56	1.78	0.67	10.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	216.33	97.00	37.46	1.61	0.62	0.74	15.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	189.62	83.21	27.74	0.93	0.70	1.17	9.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	230.67	113.02	27.97	1.16	1.62	1.16	10.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	161.42	50.66	21.77	0.68	0.68	0.82	6.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	178.96	81.84	19.36	2.42	1.21	0.45	7.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	191.38	100.35	27.24	0.72	0.54	0.36	9.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	178.32	54.23	23.24	1.72	0.43	1.15	8.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	164.41	86.39	23.18	1.40	1.29	0.43	9.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	198.92	88.51	24.12	0.89	1.55	0.89	9.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	172.25	53.53	24.09	0.76	0.76	0.00	9.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	152.51	76.67	23.20	0.93	1.02	0.09	7.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	203.13	129.84	30.82	0.19	1.69	0.56	12.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	164.42	60.91	18.98	0.66	0.40	0.80	8.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	155.84	79.62	20.54	0.49	0.97	0.68	9.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	190.96	99.11	22.34	1.15	1.34	1.15	10.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	170.34	62.15	23.71	1.17	0.85	0.75	8.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	139.03	71.76	21.58	2.24	0.56	0.28	5.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	152.95	79.81	19.82	1.54	1.37	0.51	10.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	157.72	53.97	19.51	0.18	0.55	0.18	10.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	152.06	75.79	20.97	1.35	1.35	1.10	6.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	194.90	95.64	24.98	0.54	1.34	0.40	11.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	171.01	58.50	34.20	0.94	0.00	0.47	10.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	167.46	84.52	21.03	0.40	1.19	0.20	8.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	202.51	91.67	24.79	1.40	2.34	0.70	10.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	195.95	60.96	23.22	0.41	0.83	0.62	6.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	191.57	94.90	21.68	3.10	0.88	2.21	8.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	158.13	75.41	19.64	1.46	1.25	0.84	10.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	157.06	59.62	23.15	1.35	0.81	0.67	10.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	167.57	80.89	18.22	1.02	1.02	0.68	8.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	166.96	81.55	22.17	1.16	1.74	0.58	9.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	163.51	54.33	24.59	2.58	0.69	0.17	9.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	141.97	70.37	19.48	0.69	1.23	0.27	8.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	172.87	94.40	23.48	1.31	0.49	1.15	11.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	157.82	41.76	20.28	1.36	0.17	0.85	6.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	144.41	64.95	21.45	0.44	1.04	0.00	6.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	136.74	62.11	19.46	0.80	0.53	0.80	6.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	173.39	70.93	22.40	1.52	0.97	0.69	7.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	186.43	72.14	17.38	0.24	0.71	0.24	6.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	143.50	69.53	22.57	0.60	0.40	0.00	9.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	130.53	51.14	23.07	1.13	0.19	0.47	7.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	194.94	100.97	37.03	2.10	1.05	0.35	7.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	153.22	73.44	34.45	0.60	0.60	0.60	6.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	115.66	44.92	21.30	1.10	0.00	0.49	7.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	328.80	158.07	65.06	0.87	0.44	1.16	16.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	204.43	71.79	26.16	1.22	0.00	0.00	10.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	140.45	48.53	24.41	1.51	0.00	0.00	5.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	123.27	48.86	26.92	0.90	0.68	0.23	9.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	131.50	82.37	32.35	0.90	0.30	0.30	8.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	118.43	49.36	26.80	1.18	0.35	0.24	9.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	106.94	57.63	25.83	3.63	0.00	0.21	8.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	167.67	67.91	40.27	4.81	0.60	0.00	14.42
Schwann Cells, donor1	11498-119F4	78.24	39.12	9.40	0.00	0.38	0.56	1.50
Schwann Cells, donor2	11578-120F3	153.11	71.45	37.43	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	116.55	61.34	29.36	1.75	1.75	1.97	5.92
Sebocyte, donor1	11220-116B5	134.20	141.87	12.60	0.00	1.10	0.00	4.38
Sebocyte, donor2	11301-117B5	119.94	128.68	13.33	1.38	1.38	0.00	4.60
Sebocyte, donor3	11378-118B1	63.89	79.35	13.40	1.24	1.03	0.41	3.30
Sertoli Cells, donor1	11255-116F4	160.69	101.05	24.85	1.66	4.97	0.00	6.63
Sertoli Cells, donor2	11333-117F1	177.94	96.03	39.54	8.47	0.00	8.47	2.82
Skeletal Muscle Cells, donor1	11281-116I3	222.06	187.66	52.43	0.88	4.57	0.26	4.66
Skeletal Muscle Cells, donor2	11358-117H8	122.88	60.72	9.40	1.45	2.17	0.00	1.45
Skeletal Muscle Cells, donor3	11430-118G8	186.44	78.59	16.72	1.67	0.00	0.84	4.18
Skeletal Muscle Cells, donor4	11451-119A2	368.07	241.45	30.00	3.46	0.94	1.73	9.11
Skeletal Muscle Cells, donor5	11455-119A6	308.44	207.21	30.17	3.12	1.19	1.78	7.28
Skeletal Muscle Cells, donor6	11459-119B1	332.74	237.16	29.55	2.62	1.23	1.85	9.23
Skeletal Muscle Satellite Cells, donor1	11240-116D7	308.97	321.19	49.14	2.77	3.65	0.63	9.32
Skeletal Muscle Satellite Cells, donor2	11321-117D7	227.30	207.33	40.38	1.57	1.28	1.00	7.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	254.28	233.74	36.61	2.28	3.17	1.39	10.42
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	276.26	187.21	36.31	0.84	4.21	0.42	9.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	98.43	83.96	13.75	2.17	0.72	0.00	4.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	104.30	50.64	9.36	1.10	0.41	0.41	2.89
Skin - palm, donor1	10286-104F7	255.18	136.99	2.69	0.00	0.00	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	90.82	80.87	13.26	0.86	1.15	0.43	4.04
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	67.88	44.98	10.63	0.00	1.64	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	97.37	88.67	18.05	0.91	0.78	0.65	5.32
Small Airway Epithelial Cells, donor1	11256-116F5	178.21	212.54	25.72	1.67	1.67	0.28	6.12
Small Airway Epithelial Cells, donor2	11334-117F2	108.59	94.94	18.99	0.00	1.27	0.42	4.50
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	86.06	98.96	15.01	0.42	0.63	0.00	3.81
Small Airway Epithelial Cells, donor3	11406-118E2	95.49	99.76	14.69	0.37	0.82	0.52	2.85
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	282.97	134.85	29.01	5.86	0.00	1.85	7.10
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	80.48	54.25	6.89	0.44	0.44	0.89	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	116.39	85.23	15.87	1.18	2.35	0.00	1.76
Smooth Muscle Cells - Aortic, donor1	11283-116I5	85.30	92.15	7.29	0.00	0.66	0.22	2.43
Smooth Muscle Cells - Aortic, donor2	11360-117I1	77.97	87.81	7.88	0.79	1.97	0.39	3.15
Smooth Muscle Cells - Aortic, donor3	11432-118H1	111.25	99.66	19.31	0.00	1.55	0.77	3.09
Smooth Muscle Cells - Bladder, donor1	11519-119H7	248.19	186.14	51.04	4.00	1.00	1.00	5.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	116.44	115.64	13.57	0.40	0.80	0.27	3.06
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	236.06	138.09	18.18	3.32	1.55	0.44	4.43
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	150.18	111.13	16.39	2.94	0.64	0.51	5.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	203.49	112.00	34.84	0.98	1.63	0.98	8.47
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	164.20	99.23	23.92	2.07	0.59	0.59	3.84
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	146.07	85.13	19.65	1.00	1.71	0.57	3.84
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	40.02	34.16	5.37	0.00	0.65	0.00	1.95
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	204.88	104.12	23.14	1.22	2.13	1.52	2.74
Smooth Muscle Cells - Carotid, donor1	11285-116I7	137.39	107.09	18.94	1.01	1.26	0.00	2.27
Smooth Muscle Cells - Carotid, donor2	11362-117I3	36.72	171.38	6.12	0.00	0.00	0.00	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	106.81	68.66	9.54	0.95	0.00	0.48	1.91
Smooth Muscle Cells - Colonic, donor1	11239-116D6	187.14	138.18	26.55	1.03	1.47	0.15	6.49
Smooth Muscle Cells - Colonic, donor2	11320-117D6	207.49	138.83	27.12	1.51	1.72	1.29	4.95
Smooth Muscle Cells - Colonic, donor3	11396-118D1	212.96	160.90	28.02	2.73	1.89	1.15	7.77
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	84.92	100.39	8.97	0.31	1.08	0.15	1.39
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	101.32	99.16	8.62	1.08	1.08	0.00	3.23
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	129.70	75.91	10.16	0.30	0.90	0.30	6.87
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	49.84	42.33	7.17	0.34	0.68	0.34	2.05
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	280.19	250.98	51.44	1.57	1.18	0.47	5.81
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	173.91	189.71	13.79	1.81	1.41	0.20	3.82
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	125.61	73.73	15.25	1.37	0.46	0.46	6.83
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	82.12	54.95	10.26	0.60	0.00	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	345.46	374.34	34.97	2.12	5.30	1.32	12.72
Smooth Muscle Cells - Prostate, donor1	11257-116F6	187.49	129.16	22.37	0.53	0.67	0.40	6.26
Smooth Muscle Cells - Prostate, donor2	11335-117F3	192.59	161.41	28.80	2.38	2.00	0.75	4.26
Smooth Muscle Cells - Prostate, donor3	11465-119B7	202.68	128.86	29.93	1.27	0.51	0.25	3.04
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	149.72	129.21	19.60	0.75	0.90	0.45	3.47
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	87.02	57.76	10.50	0.75	0.00	0.00	2.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	230.01	135.68	10.34	0.00	0.00	0.00	3.88
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	113.01	78.13	21.86	0.00	2.79	0.47	3.72
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	142.88	123.19	21.71	0.00	1.51	0.50	3.53
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	104.67	90.57	6.58	1.25	0.31	1.25	2.51
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	43.95	56.64	4.72	0.59	0.59	0.00	0.88
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	225.09	183.03	30.57	0.42	3.58	0.08	6.83
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	175.65	131.27	40.64	0.47	1.87	0.00	2.80
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	102.33	98.87	9.64	0.29	1.15	0.14	2.01
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	126.46	88.21	16.83	0.76	0.76	0.76	2.80
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	111.13	55.66	9.97	0.75	0.75	0.19	3.20
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	236.45	219.96	30.05	0.28	1.82	0.42	6.15
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	245.83	191.04	28.07	1.59	1.42	0.34	5.03
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	41.43	52.38	0.95	0.48	0.00	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	119.39	97.86	8.07	0.24	0.24	0.24	1.47
Smooth Muscle Cells - Uterine, donor1	11258-116F7	216.97	129.03	17.68	1.77	2.21	0.22	3.54
Smooth Muscle Cells - Uterine, donor3	11466-119B8	220.02	164.14	32.48	0.59	0.29	1.76	6.73
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	186.39	39.84	20.80	1.94	0.39	0.00	2.72
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	148.62	69.02	16.13	3.70	0.79	0.26	6.35
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	303.51	124.23	24.18	5.58	1.12	1.86	4.09
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	211.65	122.53	20.12	2.16	0.36	0.72	4.31
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	138.83	79.78	10.79	1.70	0.57	0.00	4.54
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	244.59	106.34	32.30	1.58	0.79	0.79	7.09
Smooth muscle cells - airway, control, donor1	11966-126D4	210.02	96.25	18.28	4.32	0.76	0.25	2.79
Smooth muscle cells - airway, control, donor2	11967-126D5	170.91	57.10	20.76	2.40	0.40	0.00	2.40
Smooth muscle cells - airway, control, donor3	11968-126D6	203.99	71.48	22.57	2.51	0.42	0.42	3.34
Smooth muscle cells - airway, control, donor4	11969-126D7	217.26	65.09	31.17	1.38	0.00	0.00	4.58
Synoviocyte, donor1	11291-117A4	172.02	78.44	22.89	1.18	0.17	0.50	3.20
Synoviocyte, donor2	11368-117I9	199.81	90.18	25.31	2.85	2.18	1.01	2.85
Synoviocyte, donor3	11440-118H9	271.22	71.27	20.55	2.46	1.34	1.12	1.12
Trabecular Meshwork Cells, donor1	11532-120A2	93.98	62.89	6.43	0.00	2.86	0.36	1.79
Trabecular Meshwork Cells, donor2	11612-122A1	43.60	57.48	3.96	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	56.73	41.45	8.10	0.00	0.23	0.00	0.93
Tracheal Epithelial Cells, donor1	11292-117A5	117.49	158.06	15.56	0.72	1.22	0.29	2.72
Tracheal Epithelial Cells, donor2	11369-118A1	75.77	111.72	11.21	0.39	0.00	0.00	3.87
Tracheal Epithelial Cells, donor3	11441-118I1	63.57	80.17	6.87	0.00	1.15	0.00	2.29
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	251.58	95.84	26.82	0.25	0.25	0.86	8.86
Urethra, donor2	10319-105A4	163.66	71.94	12.59	0.00	0.00	3.60	5.40
Urothelial Cells, donor1	11520-119H8	36.40	41.71	3.45	0.53	0.27	0.27	0.00
Urothelial Cells, donor2	11600-120H7	50.47	46.87	4.01	0.80	0.00	1.20	1.20
Urothelial Cells, donor3	11681-122H7	48.82	49.51	3.44	0.46	0.23	0.92	0.69
Urothelial cells, donor0	11216-116B1	183.22	193.03	16.05	0.45	0.45	0.00	1.56
Whole blood (ribopure), donor090309, donation1	12179-129A1	446.67	61.40	22.24	3.56	0.89	1.78	6.23
Whole blood (ribopure), donor090309, donation2	12180-129A2	434.60	81.49	40.03	1.43	0.00	2.86	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	295.71	49.29	17.80	4.79	1.37	0.68	4.11
Whole blood (ribopure), donor090325, donation1	12176-128I7	363.62	73.00	24.79	1.72	0.34	0.34	4.13
Whole blood (ribopure), donor090325, donation2	12177-128I8	425.31	60.43	20.92	1.16	0.00	1.74	4.65
Whole blood (ribopure), donor090612, donation1	12182-129A4	340.49	37.48	24.99	1.04	0.00	1.04	5.21
Whole blood (ribopure), donor090612, donation2	12183-129A5	431.36	63.33	22.94	3.67	0.00	0.00	2.75
Whole blood (ribopure), donor090612, donation3	12184-129A6	297.60	45.64	11.87	1.83	0.00	2.74	2.74
Wilms' tumor cell line:G-401	10809-111A8	236.48	111.89	22.33	1.36	0.99	1.73	5.67
Wilms' tumor cell line:HFWT	10597-108E3	166.33	129.37	12.32	0.00	0.88	1.76	1.76
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	271.50	167.87	22.07	3.35	3.35	0.84	6.42
achilles tendon, donor2	10292-104G4	194.25	66.13	10.33	0.00	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	315.38	171.08	61.70	2.29	2.80	1.27	24.73
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	389.82	166.70	73.13	0.70	1.39	1.16	23.68
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	303.54	113.72	48.43	1.31	2.26	0.24	13.30
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	302.86	194.29	85.44	3.81	2.72	1.09	39.18
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	133.23	62.96	15.46	2.53	0.84	0.84	3.09
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	453.63	151.84	40.18	1.27	2.33	0.85	12.48
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	382.46	160.88	50.36	5.44	2.18	2.45	7.62
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	742.48	345.46	39.66	8.37	4.85	3.08	7.93
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	363.03	96.78	45.74	8.17	2.86	3.27	10.62
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	768.44	186.77	36.89	7.38	1.94	4.27	5.05
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	384.38	243.06	48.21	6.07	2.94	2.76	18.95
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	682.59	265.24	54.61	11.70	0.00	3.90	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	288.62	130.60	52.29	6.51	0.70	2.79	13.25
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	534.63	291.78	60.07	3.88	3.11	3.88	13.98
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	356.54	212.46	45.30	5.26	0.88	4.97	17.83
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	237.49	112.01	27.89	0.93	2.79	0.46	6.51
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	230.71	63.33	32.08	3.29	0.82	0.82	14.81
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	128.92	65.07	10.44	0.61	1.53	0.61	6.45
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	376.78	170.26	34.99	1.71	2.99	0.00	8.96
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	365.77	176.21	33.67	1.21	1.52	0.61	5.76
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	383.93	209.41	39.96	1.20	1.93	0.24	11.07
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	310.50	212.05	31.63	2.45	3.56	2.23	10.69
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	242.16	163.44	19.01	1.33	2.00	1.33	4.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	180.25	176.53	26.01	1.86	1.86	0.00	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	324.68	209.80	25.99	4.52	1.88	1.13	7.53
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	189.72	65.42	29.66	0.87	1.31	0.00	5.23
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	504.23	148.08	22.49	0.00	0.00	1.87	9.37
adenocarcinoma cell line:IM95m	10796-110I4	365.73	101.03	15.54	1.41	0.71	1.41	2.59
adipose tissue, adult, pool1	10010-101C1	250.21	92.14	16.91	0.78	0.78	0.47	2.02
adipose, donor1	10184-103D4	688.44	402.28	52.19	26.39	1.76	4.10	14.66
adipose, donor2	10185-103D5	166.26	123.68	18.25	5.27	0.41	1.22	2.84
adipose, donor3	10186-103D6	209.39	117.08	25.87	5.17	1.09	2.45	7.62
adipose, donor4	10187-103D7	176.82	201.95	42.47	4.33	5.20	0.00	19.07
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	341.05	237.68	23.52	1.42	1.10	1.42	4.42
adrenal gland, adult, pool1	10081-102A9	152.78	40.01	7.28	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	348.06	230.13	35.62	1.33	0.40	0.13	4.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	538.81	276.91	25.73	2.86	0.71	2.86	3.93
amniotic membrane cells, donor1	12235-129G3	268.02	77.21	24.34	2.55	2.55	0.93	6.49
amniotic membrane cells, donor2	12236-129G4	196.44	76.75	34.49	1.35	1.69	1.35	8.11
amniotic membrane cells, donor3	12237-129G5	309.04	114.01	44.19	3.54	0.59	1.77	11.19
amygdala - adult, donor10196	10167-103B5	151.78	62.85	23.72	4.74	0.00	0.00	10.67
amygdala, adult, donor10252	10151-102I7	136.26	50.69	26.77	0.61	0.81	0.61	8.52
amygdala, newborn, donor10223	10360-105E9	161.06	71.01	20.33	0.97	0.97	0.65	8.71
anaplastic carcinoma cell line:8305C	10428-106D5	350.79	138.15	51.44	2.42	1.27	0.76	3.44
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	533.47	297.40	27.14	7.28	1.76	2.21	8.60
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	502.06	81.84	48.77	2.67	12.36	2.34	5.01
aorta, adult, pool1	10052-101G7	127.49	49.82	9.61	1.18	0.00	0.59	0.98
appendix, adult	10189-103D9	261.20	79.56	24.06	2.33	1.55	0.39	5.82
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	389.68	184.35	51.93	0.69	3.10	0.69	10.66
artery, adult	10190-103E1	243.21	76.09	17.66	1.36	0.00	1.36	2.72
astrocytoma cell line:TM-31	10425-106D2	361.15	124.59	34.33	1.45	3.62	0.29	7.24
b cell line:RPMI1788	10427-106D4	387.22	298.29	34.20	1.34	2.53	0.45	5.35
basal cell carcinoma cell line:TE 354.T	10702-109G9	154.26	85.73	10.27	1.66	0.83	0.55	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	232.90	185.17	25.90	0.30	0.79	0.69	6.25
bile duct carcinoma cell line:TFK-1	10496-107C1	286.22	104.11	23.10	1.34	0.84	0.67	5.02
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	557.00	284.09	34.11	3.36	2.24	4.47	1.12
bladder, adult, pool1	10011-101C2	328.42	141.99	23.36	1.74	1.20	1.41	2.28
blood, adult, pool1	10053-101G8	356.55	48.72	6.64	2.21	0.00	4.43	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	97.62	29.97	12.85	2.57	1.71	0.00	4.28
bone marrow, adult	10192-103E3	281.40	130.92	23.62	3.37	1.35	2.70	6.75
brain, adult, donor1	10084-102B3	75.86	34.85	16.40	0.00	0.00	2.05	1.03
brain, adult, pool1	10012-101C3	137.42	64.92	25.72	0.78	1.00	0.22	7.46
brain, fetal, pool1	10085-102B4	205.70	66.78	8.01	2.67	0.00	0.00	2.67
breast carcinoma cell line:MCF7	10482-107A5	489.60	198.22	91.51	2.97	5.62	2.64	17.18
breast carcinoma cell line:MDA-MB-453	10419-106C5	327.04	128.19	43.19	0.12	1.62	0.25	10.98
breast, adult, donor1	10080-102A8	340.93	62.50	10.73	1.26	0.63	0.00	4.42
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	378.95	198.18	37.60	2.29	4.83	1.52	6.10
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	269.02	128.02	14.53	1.55	4.64	1.24	4.95
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	366.28	374.34	38.91	4.83	1.38	1.38	7.37
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	171.88	61.49	17.43	1.45	0.73	1.45	4.12
carcinoid cell line:NCI-H1770	10703-109H1	216.75	122.24	19.75	1.41	2.35	0.94	5.64
carcinoid cell line:NCI-H727	10735-110B6	362.27	122.83	51.52	0.88	2.30	0.98	11.70
carcinoid cell line:SK-PN-DW	10719-109I8	428.44	265.24	47.53	2.85	2.22	3.17	11.73
carcinosarcoma cell line:JHUCS-1	10642-109A3	455.70	162.63	49.78	2.40	9.05	1.86	3.73
caudate nucleus - adult, donor10196	10177-103C6	247.53	42.60	19.57	2.30	0.00	0.00	10.36
caudate nucleus, adult, donor10252	10164-103B2	145.41	53.71	36.14	0.50	0.84	0.67	10.21
caudate nucleus, adult, donor10258	10379-105H1	226.95	57.31	19.87	0.76	0.00	0.00	12.23
caudate nucleus, newborn, donor10223	10354-105E3	212.78	73.61	35.16	0.00	0.73	0.73	7.32
cerebellum - adult, donor10196	10173-103C2	364.16	58.27	17.48	2.91	0.00	2.91	14.57
cerebellum, adult, donor10252	10166-103B4	177.64	38.00	25.41	1.07	0.64	0.43	6.83
cerebellum, adult, pool1	10083-102B2	294.58	45.19	12.07	2.07	0.00	1.38	2.41
cerebellum, newborn, donor10223	10357-105E6	314.68	64.76	30.72	2.49	0.83	1.66	14.11
cerebral meninges, adult	10188-103D8	191.37	68.83	21.43	2.27	0.76	1.26	7.06
cerebrospinal fluid, donor2	10294-104G6	192.95	75.28	4.39	1.46	0.73	1.46	2.19
cervical cancer cell line:D98-AH2	10552-107I3	415.68	237.67	46.01	1.58	0.86	0.86	3.16
cervical cancer cell line:ME-180	10553-107I4	366.90	152.96	39.44	1.33	3.65	0.00	8.45
cervix, adult, pool1	10013-101C4	363.37	122.84	30.45	2.20	2.52	0.84	3.88
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	241.89	115.09	20.34	1.11	2.23	0.42	6.41
chondrosarcoma cell line:SW 1353	10700-109G7	113.64	74.46	10.45	1.31	0.00	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	567.07	528.05	73.94	4.85	2.49	2.73	19.76
choriocarcinoma cell line:SCH	10785-110H2	402.04	173.73	39.67	2.71	2.22	0.99	9.36
choriocarcinoma cell line:T3M-3	10618-108G6	246.43	187.13	13.28	1.19	0.24	0.47	2.61
chorionic membrane cells, donor1	12238-129G6	219.96	70.38	28.21	2.28	1.42	1.42	10.83
chorionic membrane cells, donor2	12239-129G7	175.50	73.18	19.39	1.89	1.39	0.40	6.07
chorionic membrane cells, donor3	12240-129G8	230.23	73.08	47.26	6.04	0.00	2.20	19.78
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	367.57	115.12	71.70	3.03	6.06	5.05	25.25
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	364.80	161.75	25.36	3.27	1.92	1.92	6.15
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	318.68	119.53	34.00	1.90	1.27	0.63	8.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	285.82	267.33	27.48	1.80	1.28	0.51	7.70
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	295.58	254.94	28.54	0.48	2.18	0.48	8.47
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	310.51	248.00	34.21	1.02	2.65	0.41	7.53
chronic myelogenous leukemia cell line:K562	10454-106G4	419.60	382.79	35.04	1.47	4.12	1.77	12.07
chronic myelogenous leukemia cell line:KU812	10409-106B4	291.12	173.84	37.53	0.00	1.04	0.00	8.60
clear cell carcinoma cell line:JHOC-5	10638-108I8	285.96	149.49	42.06	4.57	0.69	3.20	8.69
clear cell carcinoma cell line:TEN	10636-108I6	368.87	180.10	44.07	3.99	1.21	0.87	9.37
colon carcinoma cell line:CACO-2	10513-107D9	243.63	132.71	35.88	1.83	3.84	0.37	15.92
colon carcinoma cell line:COLO-320	10420-106C6	776.89	500.57	79.82	2.28	7.98	0.38	9.12
colon, adult, donor1	10082-102B1	203.50	23.80	21.42	0.00	2.38	0.00	0.00
colon, adult, pool1	10014-101C5	272.84	70.03	25.26	0.47	0.94	1.18	3.88
colon, fetal, donor1	10070-101I7	359.05	79.72	17.92	1.85	1.24	1.85	3.71
common myeloid progenitor CMP, donor1	12130-128D6	96.25	64.17	13.75	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	701.03	100.15	25.04	0.00	0.00	0.00	25.04
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	298.30	245.19	27.20	0.42	0.85	0.42	9.35
cord blood derived cell line:COBL-a 24h infection	10453-106G3	355.14	214.78	33.20	1.51	0.60	0.91	13.43
cord blood derived cell line:COBL-a untreated	10449-106F8	427.12	249.59	42.30	0.85	0.42	0.42	15.37
corpus callosum, adult, pool1	10042-101F6	132.45	48.87	19.90	0.44	0.77	0.22	4.42
cruciate ligament, donor2	10295-104G7	230.17	58.35	8.92	1.62	0.00	0.81	5.67
diaphragm, fetal, donor1	10069-101I6	300.96	58.59	14.45	1.61	0.00	0.80	4.01
diencephalon, adult	10193-103E4	128.87	42.96	22.56	0.96	0.24	0.48	5.04
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	670.01	254.18	100.34	19.75	5.51	6.66	24.57
ductal cell carcinoma cell line:KLM-1	10438-106E6	265.16	196.18	52.31	1.03	3.08	1.03	14.87
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	127.34	298.50	14.44	0.72	1.20	0.24	2.89
ductus deferens, adult	10196-103E7	220.27	53.32	19.93	1.50	1.00	0.50	7.97
duodenum, fetal, donor1, tech_rep1	10071-101I8	348.54	40.33	15.84	4.32	0.00	0.00	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	309.71	60.32	20.60	3.68	0.74	2.21	6.62
dura mater, adult, donor1	10041-101F5	213.41	127.18	17.59	0.83	2.40	0.17	1.98
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	196.53	303.35	36.86	2.00	4.22	0.67	18.65
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	352.79	467.57	46.00	2.87	3.87	1.15	26.65
embryonic pancreas cell line:1B2C6	10604-108F1	204.72	93.11	19.73	0.62	1.23	1.85	4.32
embryonic pancreas cell line:1C3D3	10605-108F2	271.83	162.86	24.52	2.12	0.30	0.91	2.42
embryonic pancreas cell line:1C3IKEI	10606-108F3	213.04	116.40	18.22	0.93	1.54	0.93	4.63
embryonic pancreas cell line:2C6	10603-108E9	290.28	114.27	18.39	0.00	1.31	0.00	3.94
endometrial carcinoma cell line:OMC-2	10497-107C2	297.99	217.54	54.97	1.34	0.67	0.00	15.75
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	336.55	156.04	35.88	2.36	4.53	2.36	5.44
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	241.06	117.07	35.86	5.15	4.82	1.29	11.42
epidermoid carcinoma cell line:A431	10426-106D3	168.29	140.39	35.90	0.89	2.11	0.22	11.23
epidermoid carcinoma cell line:Ca Ski	10431-106D8	204.46	108.34	22.22	0.66	3.41	0.33	6.93
epididymis, adult	10197-103E8	226.06	72.00	23.65	2.93	1.67	1.47	4.60
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	227.26	135.19	17.74	1.06	0.53	0.53	2.13
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	251.28	135.28	27.53	1.18	1.18	1.18	7.86
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	422.64	208.37	36.17	3.15	0.66	1.70	9.83
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	360.51	166.03	31.49	1.97	0.79	1.18	7.09
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	412.60	217.45	38.87	2.80	1.34	0.78	11.31
esophagus, adult, pool1	10015-101C6	305.26	144.40	25.16	1.70	1.70	0.96	4.78
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	473.64	204.13	66.88	0.50	1.75	0.88	3.38
eye - muscle inferior rectus, donor1	10272-104E2	135.22	48.29	9.66	2.41	0.00	2.41	7.24
eye - muscle lateral, donor2	10298-104H1	254.61	61.02	8.42	0.00	0.00	2.10	0.00
eye - muscle medial, donor2	10299-104H2	191.98	56.55	5.95	0.00	0.00	0.00	4.46
eye - muscle superior, donor2	10297-104G9	144.46	60.76	6.88	1.15	0.00	2.29	3.44
eye - vitreous humor, donor1	10268-104D7	157.40	59.75	4.37	4.37	0.00	1.46	2.91
eye, fetal, donor1	10054-101G9	319.32	62.80	23.14	3.56	2.03	1.53	4.58
fibrosarcoma cell line:HT-1080	10758-110E2	292.61	205.93	29.36	2.05	2.05	0.90	6.54
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	383.19	263.06	25.17	2.37	3.32	1.19	10.21
frontal lobe, adult, pool1	10040-101F4	113.90	60.61	29.55	0.56	0.56	0.38	7.13
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	226.39	86.77	36.33	2.70	1.20	0.00	11.41
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	348.01	290.31	24.96	0.55	1.01	0.37	4.11
gall bladder, adult	10198-103E9	177.21	52.15	21.25	0.97	0.97	0.97	3.14
gamma delta positive T cells, donor1	11937-126A2	481.56	92.88	31.67	1.61	0.54	0.54	4.29
gamma delta positive T cells, donor2	11938-126A3	336.14	82.17	22.41	1.87	0.75	0.00	4.11
gastric adenocarcinoma cell line:MKN1	10614-108G2	266.56	150.81	34.43	8.24	1.27	1.90	7.18
gastric adenocarcinoma cell line:MKN45	10612-108F9	407.72	137.52	27.08	2.32	2.51	0.77	3.09
gastric cancer cell line:AZ521	10549-107H9	300.86	268.23	40.82	0.82	1.48	0.49	9.84
gastric cancer cell line:GSS	10560-108A2	337.72	199.52	27.46	0.92	0.00	1.83	2.75
gastrointestinal carcinoma cell line:ECC12	10615-108G3	266.15	75.16	50.49	3.88	1.37	2.28	10.28
giant cell carcinoma cell line:LU65	10487-107B1	192.42	163.73	7.69	1.03	2.41	0.46	1.38
giant cell carcinoma cell line:Lu99B	10433-106E1	254.17	386.85	14.42	0.98	2.24	0.28	0.84
glassy cell carcinoma cell line:HOKUG	10688-109F4	177.34	94.53	23.20	1.50	0.75	1.25	6.98
glioblastoma cell line:A172, tech_rep1	10444-106F3	151.47	82.33	22.69	0.53	4.01	0.63	7.39
glioblastoma cell line:A172, tech_rep2	10444-106F3	146.48	89.18	24.16	0.42	4.77	0.28	6.60
glioblastoma cell line:T98G	10485-107A8	196.69	111.37	17.99	0.99	1.99	0.55	3.75
glioma cell line:GI-1	10413-106B8	292.88	132.97	37.20	0.88	2.64	0.59	4.98
globus pallidus - adult, donor10196	10175-103C4	238.35	53.94	18.22	0.73	0.00	0.73	5.83
globus pallidus, adult, donor10252	10161-103A8	188.44	53.46	52.72	1.22	0.98	0.49	14.89
globus pallidus, adult, donor10258	10367-105F7	187.58	38.34	16.43	2.74	2.74	5.48	1.37
globus pallidus, newborn, donor10223	10364-105F4	151.35	55.42	22.38	0.00	0.53	1.60	9.06
granulocyte macrophage progenitor, donor1	12131-128D7	80.76	56.28	7.34	0.00	2.45	0.00	9.79
granulocyte macrophage progenitor, donor2	12135-128E2	196.71	98.36	43.71	0.00	0.00	0.00	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	334.50	193.38	52.27	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	111.68	51.20	15.36	0.32	1.60	0.64	2.88
hIPS +CCl2, biol_rep1	14383-156B9	352.60	137.28	60.14	3.67	2.30	0.92	22.04
hIPS +CCl2, biol_rep2	14384-156C1	283.05	125.75	61.73	1.37	1.37	0.46	17.83
hIPS +CCl2, biol_rep3	14385-156C2	345.23	101.77	36.71	0.00	1.93	0.64	13.53
hIPS, biol_rep1	14380-156B6	281.71	155.23	66.12	8.62	7.19	0.00	17.25
hIPS, biol_rep2	14381-156B7	259.26	73.39	34.98	1.37	1.37	0.00	27.43
hIPS, biol_rep3	14382-156B8	167.73	30.90	36.41	2.21	1.10	0.00	6.62
hairy cell leukemia cell line:Mo	10712-109I1	278.72	192.52	21.84	1.72	0.86	3.16	4.31
heart - mitral valve, adult	10205-103F7	249.94	78.03	15.85	1.20	0.60	2.09	4.19
heart - pulmonic valve, adult	10206-103F8	292.07	101.45	29.55	0.00	0.52	0.52	7.84
heart - tricuspid valve, adult	10207-103F9	291.42	89.09	10.82	1.67	0.00	0.83	6.66
heart, adult, diseased post-infarction, donor1	10050-101G5	234.46	103.46	35.51	3.06	0.61	1.02	11.84
heart, adult, diseased, donor1	10051-101G6	206.53	94.11	23.85	1.28	0.43	0.85	7.66
heart, adult, pool1	10016-101C7	259.87	111.08	22.54	1.15	0.23	0.69	4.60
heart, fetal, pool1	10046-101G1	397.17	148.48	39.43	0.21	1.13	0.10	13.45
hepatic mesenchymal tumor cell line:LI90	10778-110G4	168.76	45.66	15.43	1.23	1.54	0.31	2.16
hepatoblastoma cell line:HuH-6	10633-108I3	472.10	252.11	33.30	2.38	0.00	1.19	8.32
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	199.33	108.51	52.26	1.33	1.55	0.99	20.66
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	207.79	114.58	50.25	1.58	1.82	0.97	19.42
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	208.37	114.49	57.70	0.81	1.62	0.40	21.32
hepatoma cell line:Li-7	10484-107A7	335.65	207.86	20.80	1.89	4.89	0.22	4.23
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	291.95	178.29	59.90	2.11	4.32	0.80	18.19
hippocampus - adult, donor10196	10169-103B7	172.23	62.46	20.82	2.84	0.95	1.89	12.30
hippocampus, adult, donor10252	10153-102I9	143.48	50.62	37.15	1.22	0.20	1.02	9.80
hippocampus, adult, donor10258	10374-105G5	101.58	17.93	22.41	1.49	0.00	0.50	4.48
hippocampus, newborn, donor10223	10363-105F3	113.15	47.94	16.92	1.76	0.35	0.00	4.93
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	704.34	335.69	111.08	18.31	5.49	4.27	47.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	312.01	197.14	71.47	5.50	3.93	2.36	22.19
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	380.59	199.82	80.74	5.59	3.05	1.27	31.99
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	366.51	202.99	29.32	4.51	0.00	0.56	5.07
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	461.68	265.44	32.79	24.01	1.03	8.52	4.91
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	512.47	277.87	53.52	3.04	0.38	0.38	6.45
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	356.48	139.55	38.83	7.01	1.75	1.75	7.30
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	285.44	162.86	38.99	3.02	1.29	2.37	6.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	265.26	100.51	40.04	1.67	0.83	0.83	7.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	424.33	134.97	50.44	0.95	3.08	0.71	16.34
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	331.08	125.84	40.82	5.95	5.14	1.93	10.61
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	384.46	153.51	52.52	0.67	2.02	1.35	14.14
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	290.90	195.14	63.06	5.32	5.48	2.19	23.79
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	382.23	185.22	61.41	16.70	4.91	2.46	20.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	610.93	351.72	85.53	10.47	4.36	2.62	50.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	353.76	241.88	39.14	7.06	0.19	2.10	4.01
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	360.20	171.38	25.29	3.92	1.31	2.62	4.36
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	471.28	209.40	31.98	14.99	0.00	0.50	10.49
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	295.77	255.65	27.51	7.72	1.32	4.14	3.01
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	366.05	207.81	25.92	6.82	0.00	3.64	2.73
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	315.12	187.63	37.59	3.45	2.19	1.88	3.76
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	247.40	98.80	30.05	3.27	1.63	1.31	8.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	261.57	87.09	27.87	3.77	1.74	0.58	7.84
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	248.11	70.84	36.77	3.59	2.69	0.30	9.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	333.83	224.10	68.36	6.28	4.99	2.77	27.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	323.80	185.72	56.77	3.42	4.56	1.43	14.83
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	607.98	264.18	102.49	7.35	8.17	2.45	29.81
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	366.87	169.35	35.56	8.45	1.41	2.82	8.10
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	280.63	171.36	24.39	4.43	1.58	0.95	5.70
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	330.16	178.85	40.55	2.12	2.72	1.21	9.38
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	287.00	151.52	25.86	4.14	0.52	0.52	4.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	288.25	140.80	26.57	4.65	1.33	0.00	5.31
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	293.73	126.98	43.61	4.36	2.31	1.03	8.72
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	297.83	100.73	33.49	6.14	2.05	3.58	5.62
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	327.12	124.18	36.35	6.06	2.27	3.03	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	312.53	107.87	32.26	3.70	3.02	2.35	11.43
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	348.98	235.23	66.90	7.00	4.11	0.48	18.60
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	481.31	269.18	94.03	10.25	5.35	2.23	38.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	413.66	222.93	68.78	10.73	6.34	2.93	27.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	316.31	189.79	29.03	3.36	0.61	2.14	6.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	2622.11	1184.18	182.18	71.57	3.25	26.03	45.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	585.11	313.73	50.97	7.28	1.99	2.98	11.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	268.72	160.91	29.01	4.93	1.64	1.64	4.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	361.88	155.25	37.27	3.26	1.45	0.72	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	332.38	156.94	39.50	4.27	2.14	2.14	8.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	280.45	108.60	35.80	2.39	1.19	0.00	7.16
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	361.99	129.20	43.20	3.11	2.17	0.41	9.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	283.40	98.06	34.48	2.69	1.35	0.81	13.20
immature langerhans cells, donor1	11904-125F5	230.28	118.65	28.33	0.97	0.97	0.97	3.63
immature langerhans cells, donor2	11905-125F6	157.63	72.88	22.18	0.79	3.17	0.79	2.38
insula, adult, pool1	10039-101F3	93.31	56.97	25.27	0.09	0.85	0.00	8.23
keratoacanthoma cell line:HKA-1	10791-110H8	289.06	54.95	22.44	2.93	1.63	0.00	3.25
kidney, adult, pool1	10017-101C8	200.96	75.50	17.12	0.80	1.10	0.70	6.11
kidney, fetal, pool1	10045-101F9	160.64	64.23	15.28	0.42	1.49	0.28	1.91
large cell lung carcinoma cell line:IA-LM	10509-107D5	345.25	271.69	43.88	0.71	1.99	0.28	10.94
large cell lung carcinoma cell line:NCI-H460	10839-111E2	454.54	178.06	26.13	7.33	0.55	3.46	2.35
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	209.19	112.85	15.41	0.18	2.57	0.37	1.83
left atrium, adult, donor1	10079-102A7	277.87	73.01	13.08	2.18	0.00	0.54	4.90
left ventricle, adult, donor1	10078-102A6	231.08	61.69	9.61	0.51	0.00	1.01	2.53
leiomyoblastoma cell line:G-402	10721-110A1	327.24	184.14	16.96	1.37	1.09	0.82	3.83
leiomyoma cell line:10964C	10569-108B2	125.74	133.64	14.01	1.44	1.44	2.16	1.80
leiomyoma cell line:15242A	10570-108B3	137.50	125.54	9.78	0.54	2.17	1.63	4.89
leiomyoma cell line:15425	10571-108B4	152.00	138.40	15.30	4.37	0.49	1.21	3.16
leiomyosarcoma cell line:Hs 5.T	10722-110A2	146.04	114.29	0.00	0.00	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	177.74	89.92	9.41	0.00	1.05	1.05	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	308.01	178.50	47.34	2.13	0.94	1.77	12.04
liposarcoma cell line:KMLS-1	10782-110G8	171.99	97.63	20.78	1.25	1.25	0.62	5.15
liposarcoma cell line:SW 872	10726-110A6	166.68	42.16	17.06	1.34	1.58	0.61	3.53
liver, adult, pool1	10018-101C9	228.34	125.92	15.40	0.49	0.32	0.16	3.73
liver, fetal, pool1	10086-102B5	100.66	32.92	3.76	0.94	0.94	0.00	1.88
locus coeruleus - adult, donor10196	10182-103D2	131.10	53.08	26.83	1.02	0.58	0.29	8.31
locus coeruleus, adult, donor10252	10165-103B3	142.66	56.66	30.82	0.74	0.92	0.74	9.60
locus coeruleus, adult, donor10258	10375-105G6	154.61	42.88	17.77	0.85	1.13	0.85	8.46
locus coeruleus, newborn, donor10223	10362-105F2	321.77	105.15	26.50	3.36	0.84	0.42	16.82
lung adenocarcinoma cell line:A549	10499-107C4	223.37	135.63	29.20	0.42	0.83	0.42	5.26
lung adenocarcinoma cell line:PC-14	10408-106B3	221.30	137.19	16.55	0.69	1.38	0.00	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	283.40	172.81	27.55	1.19	0.92	0.79	10.81
lung, adult, pool1	10019-101D1	197.75	86.59	16.89	0.47	0.00	0.47	3.43
lung, fetal, donor1	10068-101I5	363.32	95.90	39.39	1.43	0.86	0.57	9.42
lung, right lower lobe, adult, donor1	10075-102A3	217.19	40.32	9.16	4.58	0.46	1.83	1.37
lymph node, adult, donor1	10077-102A5	353.13	64.38	12.31	5.21	0.00	1.42	0.47
lymphangiectasia cell line:DS-1	10727-110A7	501.48	196.38	24.99	1.32	1.32	1.10	4.82
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	658.49	357.24	79.54	5.13	7.40	2.41	27.77
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	175.85	132.52	22.94	0.00	2.55	0.00	7.65
mature adipocyte, donor1	12231-129F8	182.92	101.67	19.09	0.00	0.89	0.44	6.22
mature adipocyte, donor2	12232-129F9	213.75	92.35	20.96	1.04	0.00	0.00	4.57
mature adipocyte, donor3	12233-129G1	212.41	88.19	18.97	0.24	0.24	0.71	2.13
mature adipocyte, donor4	12234-129G2	273.48	119.76	26.58	1.32	0.00	0.53	5.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	548.00	298.06	50.03	1.43	7.39	1.67	11.20
medial frontal gyrus - adult, donor10196	10170-103B8	139.88	50.76	31.58	0.00	0.00	0.00	6.77
medial frontal gyrus, adult, donor10252	10150-102I6	131.68	42.30	27.77	0.55	1.10	1.10	11.77
medial frontal gyrus, adult, donor10258	10368-105F8	184.58	37.49	16.52	2.54	0.64	0.32	6.67
medial frontal gyrus, newborn, donor10223	10352-105E1	288.73	124.96	35.40	2.13	0.85	1.28	16.21
medial temporal gyrus - adult, donor10196	10183-103D3	166.73	67.33	35.78	6.24	0.68	1.35	11.31
medial temporal gyrus, adult, donor10252	10156-103A3	132.43	43.08	27.16	0.64	0.85	1.27	8.91
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	94.39	28.89	23.12	0.00	0.00	0.00	9.63
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	416.25	143.54	71.77	0.00	0.00	0.00	43.06
medial temporal gyrus, newborn, donor10223	10353-105E2	145.73	68.56	21.89	0.72	1.08	0.36	6.82
medulla oblongata - adult, donor10196	10174-103C3	278.41	52.57	14.28	1.95	1.30	3.24	3.89
medulla oblongata, adult, donor10252	10155-103A2	144.59	46.91	34.83	1.24	1.08	0.31	8.51
medulla oblongata, adult, pool1	10038-101F2	99.50	52.16	17.63	0.16	1.47	0.24	6.53
medulla oblongata, newborn, donor10223	10361-105F1	158.31	47.56	26.04	0.35	0.69	0.69	10.42
medulloblastoma cell line:D283 Med	10838-111E1	584.08	330.35	46.28	7.75	3.99	2.44	6.86
medulloblastoma cell line:ONS-76	10759-110E3	158.71	91.34	26.78	1.47	3.30	0.37	10.39
melanoma cell line:COLO 679	10514-107E1	153.95	90.85	40.25	0.72	6.32	0.00	9.92
melanoma cell line:G-361	10465-106H6	230.47	163.96	13.03	1.90	1.09	1.63	2.99
meningioma cell line:HKBMM	10691-109F7	247.12	146.71	17.01	4.70	0.72	1.09	2.89
merkel cell carcinoma cell line:MKL-1	10843-111E6	288.14	84.59	28.20	4.41	4.41	1.76	7.93
merkel cell carcinoma cell line:MS-1	10844-111E7	192.86	63.25	23.85	2.33	1.30	0.52	13.74
mesenchymal precursor cell - adipose, donor1	11747-123G1	309.48	186.88	36.52	3.07	1.53	1.53	8.13
mesenchymal precursor cell - adipose, donor2	11748-123G2	294.12	123.07	39.45	2.54	1.09	0.55	4.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	171.44	121.33	29.82	2.07	0.83	0.41	10.35
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	341.07	101.56	27.25	1.40	0.14	0.56	5.48
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	372.04	98.02	33.12	2.12	0.19	0.39	4.81
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	154.78	93.70	16.66	1.39	0.69	0.69	5.55
mesenchymal precursor cell - cardiac, donor1	11752-123G6	371.07	149.49	23.34	2.23	0.17	1.03	5.32
mesenchymal precursor cell - cardiac, donor2	11753-123G7	225.66	93.97	27.95	2.42	0.58	0.69	7.02
mesenchymal precursor cell - cardiac, donor3	11754-123G8	231.19	119.51	27.99	1.33	0.93	1.19	7.30
mesenchymal precursor cell - cardiac, donor4	11755-123G9	196.62	112.35	23.63	1.89	0.81	1.49	6.62
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	174.27	96.74	20.63	1.56	0.71	0.43	5.69
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	201.57	89.26	19.43	0.99	0.00	0.00	2.96
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	243.53	97.55	21.31	0.97	0.83	0.69	6.37
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	148.71	105.42	24.78	1.75	0.35	0.70	7.33
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	289.91	105.96	19.60	1.84	0.00	0.00	2.86
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	125.45	60.03	16.53	0.72	0.36	0.36	1.80
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	165.31	66.21	16.14	0.72	0.21	0.31	2.17
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	77.52	57.00	6.38	0.91	0.68	0.46	2.05
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	217.33	140.13	31.05	1.68	0.84	0.84	11.33
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	257.33	87.27	19.58	2.54	0.75	0.30	5.53
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	198.26	94.45	27.31	1.40	0.53	0.79	4.90
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	200.28	88.36	13.99	4.42	0.00	1.10	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	110.74	51.22	7.73	2.29	0.57	0.86	2.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	223.98	132.62	32.42	5.89	1.26	2.95	16.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	234.73	80.37	31.05	0.91	0.91	2.28	5.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	216.65	100.52	33.51	2.30	1.79	0.00	5.63
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	180.35	96.06	38.48	0.26	1.83	0.52	6.81
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	169.76	97.36	31.12	1.23	1.85	0.92	5.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	199.58	92.49	29.89	2.82	1.65	1.18	7.30
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	194.27	87.66	35.88	1.69	1.35	0.34	3.72
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	179.59	80.56	30.26	1.57	2.36	1.18	7.86
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	187.21	90.36	33.83	0.93	1.39	2.32	8.80
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	144.91	96.61	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	239.10	117.96	38.65	1.44	0.87	1.73	7.21
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	192.09	93.26	38.37	1.12	2.45	0.45	5.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	196.85	99.02	35.33	1.44	0.72	0.24	6.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	186.27	91.67	30.07	0.73	1.47	0.00	3.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	178.23	89.28	34.57	0.34	2.01	1.34	4.03
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	193.64	84.33	31.93	0.82	0.82	0.82	10.64
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	204.04	97.51	40.38	0.86	0.86	1.29	5.15
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	164.06	103.91	24.61	0.00	0.00	2.73	5.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	180.77	98.13	36.15	5.16	0.00	5.16	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	214.36	93.86	32.15	6.17	0.97	0.97	4.55
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	219.70	85.84	33.46	1.45	0.00	0.00	7.27
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	207.37	97.02	31.98	5.33	3.20	1.07	8.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	184.00	83.41	31.89	7.36	1.64	1.64	4.91
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	181.14	93.29	37.71	5.83	0.39	2.33	3.89
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	178.39	98.64	35.68	4.20	4.20	2.10	12.59
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	182.80	100.34	34.77	5.96	0.99	1.99	7.95
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	219.29	57.21	23.84	4.77	0.00	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	202.20	76.49	30.24	5.93	0.59	2.96	5.93
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	196.17	86.51	21.93	4.87	2.44	1.22	7.31
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	135.26	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	192.55	94.37	32.30	3.80	1.27	0.00	6.33
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	201.08	94.16	40.35	4.83	0.69	2.41	5.17
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	174.09	77.37	32.24	10.75	0.00	4.30	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	187.61	67.86	23.95	0.00	0.00	0.00	7.98
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	261.74	96.43	41.33	6.89	0.00	0.00	6.89
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	207.40	96.57	39.12	5.70	0.41	1.63	8.15
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	251.84	104.07	46.08	6.36	0.00	0.79	3.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	239.35	87.84	39.50	4.13	1.18	2.36	3.54
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	260.90	87.90	43.02	2.49	0.94	1.87	7.17
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	255.30	98.91	48.12	4.01	0.00	1.34	6.68
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	261.37	105.26	28.38	7.10	0.00	2.37	5.91
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	264.50	161.78	12.84	20.54	0.00	2.57	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	289.13	111.52	27.54	6.88	0.00	4.82	4.82
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	258.29	121.23	26.22	2.97	0.49	0.99	6.93
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	208.60	118.88	17.94	4.49	0.00	1.12	4.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	228.98	104.95	18.45	5.09	0.64	1.27	4.45
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	159.58	93.09	18.94	1.61	0.00	2.82	4.84
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	141.74	93.77	10.90	4.36	0.00	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	117.84	69.69	8.87	3.80	0.00	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	235.47	168.71	23.67	3.64	0.00	1.21	6.07
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	234.99	194.32	36.15	9.04	0.00	9.04	13.56
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	224.86	117.79	15.65	9.06	0.00	2.47	4.12
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	237.91	100.80	21.03	1.79	0.99	1.39	3.57
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	208.65	73.01	17.52	3.57	0.00	1.30	3.57
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	217.99	79.45	18.34	6.11	0.00	1.02	6.11
mesodermal tumor cell line:HIRS-BM	10696-109G3	109.87	44.88	20.89	0.77	0.00	0.00	2.32
mesothelioma cell line:ACC-MESO-1	10493-107B7	219.94	168.91	7.32	0.47	4.25	0.71	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	188.35	84.10	17.38	0.00	3.01	0.46	5.79
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	205.13	106.84	47.01	0.00	4.27	0.00	21.37
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	276.50	180.53	36.99	3.08	2.47	1.44	11.20
mesothelioma cell line:Mero-25	10850-111F4	144.57	91.24	20.20	1.36	7.94	0.68	8.17
mesothelioma cell line:Mero-41	10851-111F5	309.99	177.49	28.11	3.67	6.11	1.96	6.60
mesothelioma cell line:Mero-48a	10852-111F6	192.87	103.63	30.34	1.99	2.44	1.99	7.09
mesothelioma cell line:Mero-82	10853-111F7	179.50	108.54	43.36	2.37	2.63	1.84	11.83
mesothelioma cell line:Mero-83	10854-111F8	160.01	92.09	23.32	3.40	0.85	0.85	5.45
mesothelioma cell line:Mero-84	10855-111F9	112.74	55.61	19.72	1.01	3.79	0.51	4.55
mesothelioma cell line:Mero-95	10856-111G1	119.88	69.77	34.78	0.83	3.73	0.41	8.07
mesothelioma cell line:NCI-H2052	10847-111F1	228.76	139.31	23.03	3.15	2.82	0.99	8.78
mesothelioma cell line:NCI-H226	10846-111E9	335.74	196.20	60.99	3.62	2.71	1.63	19.73
mesothelioma cell line:NCI-H2452	10848-111F2	278.44	139.05	30.41	2.56	2.05	1.37	7.00
mesothelioma cell line:NCI-H28	10845-111E8	307.90	144.79	28.50	2.29	0.76	0.76	6.36
mesothelioma cell line:No36	10857-111G2	239.76	156.58	15.33	2.94	2.61	0.65	2.28
mesothelioma cell line:ONE58	10858-111G3	190.75	125.18	19.78	3.52	0.54	2.71	4.34
migratory langerhans cells, donor1	11901-125F2	130.51	56.43	21.69	1.15	0.38	1.15	6.91
migratory langerhans cells, donor2	11902-125F3	78.52	24.30	15.63	0.98	0.12	0.24	5.25
migratory langerhans cells, donor3	11903-125F4	216.63	86.15	42.00	1.79	0.18	0.18	6.64
mixed mullerian tumor cell line:HTMMT	10689-109F5	193.60	109.37	30.69	6.20	1.63	1.96	6.86
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	143.27	53.83	31.58	2.54	1.06	0.64	18.23
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	282.42	174.61	25.57	1.15	1.15	0.46	6.91
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	321.40	103.33	23.60	2.28	0.38	0.38	4.95
myelodysplastic syndrome cell line:SKM-1	10772-110F7	331.70	111.98	54.33	4.44	1.48	0.92	8.87
myeloma cell line:PCM6	10474-106I6	488.04	153.39	65.82	2.57	1.38	0.59	18.38
myxofibrosarcoma cell line:MFH-ino	10600-108E6	131.90	57.32	19.28	1.01	0.51	1.01	7.10
myxofibrosarcoma cell line:NMFH-1	10684-109E9	277.15	81.59	29.62	0.98	0.20	0.78	6.86
nasal epithelial cells, donor1, tech_rep1	12226-129F3	191.54	272.99	13.26	0.56	2.67	0.45	1.56
nasal epithelial cells, donor1, tech_rep2	12226-129F3	220.03	269.75	14.93	0.96	2.65	0.59	3.68
nasal epithelial cells, donor2	12227-129F4	131.37	208.65	18.22	0.00	2.76	0.55	4.42
neuroblastoma cell line:CHP-134	10508-107D4	565.72	142.18	83.74	1.15	1.84	0.69	5.52
neuroblastoma cell line:NB-1	10539-107G8	359.20	200.37	40.78	0.94	2.62	0.56	7.30
neuroblastoma cell line:NBsusSR	10607-108F4	1021.54	358.72	116.83	5.90	7.17	2.32	29.31
neuroblastoma cell line:NH-12	10555-107I6	635.27	161.57	88.14	2.98	1.86	1.49	7.83
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	602.32	150.40	61.68	5.93	1.90	2.85	2.14
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	660.61	273.36	39.12	10.45	4.28	4.12	5.86
neuroectodermal tumor cell line:TASK1	10774-110F9	335.70	127.20	43.67	2.21	1.81	1.01	4.23
neuroepithelioma cell line:SK-N-MC	10728-110A8	325.51	172.29	31.15	1.27	9.54	0.00	3.18
neurofibroma cell line:Hs 53.T	10729-110A9	150.92	68.40	17.30	1.33	1.06	0.27	4.26
neutrophil PMN, donor1	12133-128D9	29.75	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	159.37	26.56	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	94.71	28.41	9.47	0.00	0.00	0.00	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	611.54	253.85	66.46	1.35	1.52	1.86	10.32
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	403.46	188.12	37.62	0.00	0.80	0.80	14.41
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	217.05	69.89	33.34	4.49	2.89	2.24	4.49
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	155.29	96.17	20.23	2.10	1.58	1.31	3.68
nucleus accumbens, adult, pool1	10037-101F1	100.68	47.81	23.34	0.28	0.66	0.19	7.12
occipital cortex - adult, donor10196	10172-103C1	267.85	35.03	22.66	0.00	0.00	0.00	12.36
occipital cortex, adult, donor10252	10163-103B1	156.46	48.04	34.35	1.07	0.81	1.34	10.73
occipital cortex, newborn, donor10223	10355-105E4	151.04	64.42	25.48	1.09	0.36	0.36	8.73
occipital lobe, adult, donor1	10076-102A4	179.22	46.18	23.09	4.99	0.26	2.10	8.13
occipital lobe, fetal, donor1	10073-102A1	590.01	64.79	20.17	14.16	0.86	3.43	4.29
occipital pole, adult, pool1	10036-101E9	71.75	35.87	15.14	0.39	0.95	0.08	3.31
olfactory region, adult	10195-103E6	125.90	42.60	19.49	0.76	0.76	0.96	5.16
optic nerve, donor1	10277-104E7	162.08	42.02	14.01	0.00	4.00	4.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	223.15	130.88	33.60	1.37	2.39	0.11	11.16
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	185.06	166.79	25.14	0.82	2.20	0.41	5.22
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	232.31	128.01	40.98	5.08	2.03	1.69	10.67
oral squamous cell carcinoma cell line:SAS	10544-107H4	227.21	127.41	39.62	1.39	1.16	0.58	4.74
osteoclastoma cell line:Hs 706.T	10704-109H2	109.94	55.56	19.11	1.47	0.00	0.59	3.23
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	300.86	241.99	27.10	0.93	0.93	1.87	10.28
osteosarcoma cell line:HS-Os-1	10558-107I9	285.86	161.16	18.03	0.42	2.76	0.21	4.67
ovary, adult, pool1	10020-101D2	422.34	131.20	29.87	1.75	3.14	0.79	3.76
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	177.09	120.44	26.58	1.28	0.92	1.10	7.88
pancreas, adult, donor1	10049-101G4	321.70	56.44	23.52	1.88	0.00	0.94	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	340.19	142.00	25.44	1.12	1.68	1.12	4.75
papillary adenocarcinoma cell line:8505C	10437-106E5	268.82	93.01	20.95	6.13	1.87	3.07	4.43
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	226.52	102.83	20.53	0.99	0.17	0.66	1.82
paracentral gyrus, adult, pool1	10035-101E8	89.23	53.08	21.42	0.46	1.28	0.00	6.32
parietal cortex, adult, donor10258	10373-105G4	102.76	47.71	26.42	0.00	0.00	0.00	4.40
parietal lobe - adult, donor10196	10171-103B9	136.37	37.62	27.27	0.94	0.94	1.88	17.87
parietal lobe, adult, donor10252	10157-103A4	144.23	45.04	23.94	1.14	1.14	0.29	7.98
parietal lobe, adult, pool1	10034-101E7	88.91	44.41	22.47	0.09	0.53	0.09	6.52
parietal lobe, fetal, donor1	10072-101I9	637.18	74.68	25.22	4.85	0.97	8.73	1.94
parietal lobe, newborn, donor10223	10356-105E5	179.08	81.88	28.79	0.37	0.75	0.37	9.35
parotid gland, adult	10199-103F1	330.53	77.70	32.68	0.62	1.23	0.00	4.32
penis, adult	10200-103F2	253.52	78.42	15.58	2.69	0.54	1.07	4.83
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	546.65	255.10	19.90	2.42	3.53	2.05	1.49
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	321.26	107.96	32.49	2.33	5.39	1.75	9.47
pineal gland - adult, donor10196	10179-103C8	125.78	39.99	13.55	0.65	0.00	0.00	6.45
pineal gland, adult, donor10252	10160-103A7	152.79	49.15	26.06	0.00	0.00	1.18	10.07
pineal gland, adult, donor10258	10377-105G8	203.17	52.05	15.05	0.00	0.00	0.00	6.90
pituitary gland - adult, donor10196	10180-103C9	346.04	91.06	30.35	5.06	3.04	0.00	5.06
pituitary gland, adult, donor10252	10162-103A9	281.44	97.46	36.48	1.04	1.56	0.52	8.34
pituitary gland, adult, donor10258	10378-105G9	381.36	111.51	32.35	4.26	0.85	0.00	4.26
placenta, adult, pool1	10021-101D3	174.15	65.79	22.36	0.97	0.75	0.65	13.01
plasma cell leukemia cell line:ARH-77	10840-111E3	392.91	289.88	29.00	3.05	1.59	1.72	5.83
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	190.04	64.43	33.31	2.02	0.78	0.31	7.47
pons, adult, pool1	10033-101E6	100.53	52.50	22.12	0.17	1.03	0.17	6.63
postcentral gyrus, adult, pool1	10032-101E5	78.72	42.72	17.61	0.44	1.13	0.26	5.06
promyelocytes/myelocytes PMC, donor1	12132-128D8	12.55	18.82	8.37	0.00	0.00	0.00	8.37
promyelocytes/myelocytes PMC, donor2	12136-128E3	435.13	165.24	33.05	0.00	0.00	0.00	11.02
promyelocytes/myelocytes PMC, donor3	12140-128E7	434.22	176.04	35.21	0.00	0.00	0.00	11.74
prostate cancer cell line:DU145	10490-107B4	235.83	254.76	25.49	2.04	1.75	1.02	9.91
prostate cancer cell line:PC-3	10439-106E7	221.07	154.46	18.88	2.18	2.54	0.91	8.35
prostate, adult, pool1	10022-101D4	294.02	98.67	28.30	0.63	1.09	0.45	3.99
putamen, adult, donor10196	10176-103C5	177.05	64.92	44.38	0.94	0.47	0.71	14.16
putamen, adult, donor10252	10152-102I8	223.52	70.59	37.25	0.00	0.00	0.00	17.65
putamen, adult, donor10258, tech_rep1	10372-105G3	182.50	68.85	54.64	1.09	3.28	1.09	9.84
putamen, adult, donor10258, tech_rep2	10372-105G3	199.57	39.87	29.96	2.42	0.72	0.97	9.66
putamen, newborn, donor10223	10365-105F5	403.32	137.94	50.23	2.25	0.75	0.75	14.99
rectal cancer cell line:TT1TKB	10469-106I1	275.22	137.32	43.06	0.29	2.04	0.29	9.31
rectum, fetal, donor1	10067-101I4	582.83	94.59	13.91	2.78	0.00	0.00	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	251.64	141.19	22.90	1.06	1.70	0.00	5.51
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	226.57	196.34	12.43	4.14	0.41	0.83	0.41
retina, adult, pool1	10030-101E3	143.43	56.66	11.33	0.30	1.19	0.30	1.69
retinoblastoma cell line:Y79	10475-106I7	381.13	155.88	40.27	1.30	1.82	0.78	7.27
rhabdomyosarcoma cell line:KYM-1	10787-110H4	187.99	98.97	35.16	1.35	0.74	0.98	12.54
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	477.76	277.54	77.89	0.84	6.75	1.41	13.78
sacrococcigeal teratoma cell line:HTST	10695-109G2	207.65	103.07	22.74	1.52	0.00	1.52	3.79
salivary acinar cells, donor1	11771-123I7	345.73	227.57	19.91	2.75	0.16	1.29	3.08
salivary acinar cells, donor2	11772-123I8	383.73	139.75	17.76	3.99	0.41	1.93	1.65
salivary acinar cells, donor3	11773-123I9	264.82	96.66	13.24	0.66	0.00	1.99	0.00
salivary gland, adult, pool1	10093-102C3	182.45	40.61	30.89	0.00	0.00	0.57	3.43
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	243.83	171.57	28.67	1.26	1.77	0.25	4.64
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	243.68	162.57	30.45	1.65	1.88	0.94	4.35
seminal vesicle, adult	10201-103F3	196.29	61.37	17.99	3.17	0.00	5.29	7.94
serous adenocarcinoma cell line:JHOS-2	10639-108I9	209.64	85.51	33.28	5.10	0.97	0.73	13.12
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	228.99	76.50	30.45	3.27	2.01	0.75	7.55
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	232.82	150.53	46.16	0.00	2.01	1.00	14.05
serous cystadenocarcinoma cell line:HTOA	10693-109F9	352.19	257.09	53.59	2.69	2.55	1.48	17.86
signet ring carcinoma cell line:Kato III	10436-106E4	246.48	169.44	29.62	0.66	1.66	0.11	6.08
signet ring carcinoma cell line:NUGC-4	10483-107A6	375.59	199.60	40.00	0.77	1.03	0.65	9.55
skeletal muscle - soleus muscle, donor1	10282-104F3	432.69	278.06	15.61	0.71	2.84	0.71	5.67
skeletal muscle, adult, pool1	10023-101D5	524.25	289.77	35.74	0.96	0.84	0.48	9.59
skeletal muscle, fetal, donor1	10066-101I3	683.41	142.71	36.18	9.05	1.01	0.00	6.03
skin, adult, donor1	10074-102A2	393.54	88.21	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	353.49	85.22	32.82	20.20	0.63	2.52	2.52
small cell cervical cancer cell line:HCSC-1	10800-110I8	315.18	115.40	31.35	1.33	5.00	1.33	9.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	222.53	49.49	18.28	3.15	0.32	0.95	3.47
small cell lung carcinoma cell line:DMS 144	10841-111E4	492.47	236.69	17.93	6.17	16.96	2.12	4.82
small cell lung carcinoma cell line:LK-2	10541-107H1	530.74	391.96	42.53	1.32	10.88	0.66	8.08
small cell lung carcinoma cell line:NCI-H82	10842-111E5	522.12	616.05	33.30	3.54	2.41	3.86	2.90
small cell lung carcinoma cell line:WA-hT	10562-108A4	111.79	37.05	36.39	0.22	1.96	0.44	15.25
small intestine, adult, pool1	10024-101D6	247.13	56.97	17.92	0.96	0.84	0.24	4.66
small intestine, fetal, donor1	10064-101I1	292.13	78.62	21.87	5.90	1.23	2.21	3.93
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	136.43	60.52	14.87	3.08	1.54	3.08	2.56
smooth muscle, adult, pool1	10048-101G3	264.66	71.59	26.62	1.81	1.55	1.29	2.07
somatostatinoma cell line:QGP-1	10781-110G7	278.47	87.64	24.66	1.34	1.07	1.61	2.41
spinal cord - adult, donor10196	10181-103D1	172.05	62.17	19.96	1.38	0.92	1.38	8.26
spinal cord, adult, donor10252	10159-103A6	184.91	55.59	34.30	0.00	0.39	0.00	11.43
spinal cord, adult, donor10258	10369-105F9	295.40	40.82	24.21	2.77	0.69	1.38	8.99
spinal cord, fetal, donor1	10056-101H2	133.55	40.86	17.08	4.27	0.61	0.61	6.71
spinal cord, newborn, donor10223	10359-105E8	271.85	82.66	36.28	2.76	0.92	1.38	10.10
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	126.95	70.05	19.86	0.75	1.49	0.30	4.03
spleen, adult, pool1	10025-101D7	215.75	51.65	18.17	0.66	0.44	0.44	3.96
spleen, fetal, pool1	10044-101F8	139.60	48.71	10.73	0.48	0.40	0.08	3.42
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	340.35	222.65	28.47	1.86	0.83	0.52	7.04
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	210.19	157.79	28.29	1.14	1.90	0.76	7.22
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	324.64	132.44	56.96	5.59	3.15	2.80	23.06
squamous cell carcinoma cell line:T3M-5	10616-108G4	320.56	281.86	29.32	2.35	1.17	1.17	8.60
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	156.57	76.43	24.76	0.34	4.61	0.56	10.58
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	414.28	149.11	37.28	4.66	0.85	0.42	12.28
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	270.34	77.42	13.96	1.69	0.85	0.42	4.23
stomach, fetal, donor1	10062-101H8	256.31	81.17	9.61	2.14	0.00	1.07	2.14
submaxillary gland, adult	10202-103F4	283.70	50.70	31.90	5.13	0.57	3.42	4.56
substantia nigra - adult, donor10196	10178-103C7	108.55	162.82	0.00	0.00	54.27	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	167.00	44.86	31.99	1.45	0.21	0.83	10.18
substantia nigra, adult, donor10258	10371-105G2	140.17	22.24	19.14	0.52	0.00	0.00	2.59
substantia nigra, newborn, donor10223	10358-105E7	146.26	43.10	26.14	0.00	0.00	0.00	4.95
synovial sarcoma cell line:HS-SY-II	10441-106E9	299.88	147.42	38.06	2.52	2.98	1.38	8.71
temporal lobe, adult, pool1	10031-101E4	78.84	48.49	20.26	0.17	0.76	0.17	4.66
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	361.12	49.86	15.67	10.68	2.14	2.14	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	241.31	49.23	19.78	6.59	0.44	2.64	1.76
tenocyte, donor1	11763-123H8	162.68	67.38	22.34	2.79	0.35	1.05	3.14
tenocyte, donor2	11765-123I1	157.94	67.91	16.79	1.14	0.38	0.38	3.05
tenocyte, donor3	11768-123I4	149.38	75.99	20.39	1.11	1.85	0.00	3.71
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	326.49	200.89	32.63	3.23	0.85	1.53	8.16
teratocarcinoma cell line:NCR-G1	10798-110I6	313.23	134.26	32.53	4.16	1.70	0.62	8.94
teratocarcinoma cell line:PA-1	10807-111A6	389.46	236.50	44.32	4.03	1.24	1.08	8.37
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	441.52	243.61	53.44	3.55	2.29	1.65	19.42
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	560.83	297.24	117.23	2.65	3.03	0.76	23.82
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	421.53	332.20	35.45	2.51	0.65	1.09	6.54
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	343.94	136.80	51.79	2.93	4.89	2.61	19.54
testis, adult, pool1	10026-101D8	202.72	85.15	21.58	1.40	4.08	0.21	6.87
testis, adult, pool2	10096-102C6	124.05	54.58	14.89	1.35	7.22	1.80	6.32
thalamus - adult, donor10196	10168-103B6	147.93	51.89	16.56	3.31	0.00	2.21	9.94
thalamus, adult, donor10252	10154-103A1	164.72	42.82	40.79	0.63	0.47	0.78	13.13
thalamus, adult, donor10258, tech_rep1	10370-105G1	140.11	26.17	47.73	0.00	0.00	0.00	13.86
thalamus, adult, donor10258, tech_rep2	10370-105G1	103.92	23.39	10.87	1.32	0.33	0.66	5.76
thalamus, newborn, donor10223	10366-105F6	144.98	52.35	18.99	1.15	2.30	1.73	8.05
throat, adult	10209-103G2	278.13	89.13	20.97	6.24	1.25	1.00	7.24
throat, fetal, donor1	10061-101H7	329.69	71.61	22.24	3.05	1.52	0.91	5.48
thymic carcinoma cell line:Ty-82	10803-111A2	480.73	243.05	83.47	4.97	9.54	0.40	23.05
thymus, adult, pool1	10027-101D9	265.44	76.15	34.40	0.89	1.39	0.60	10.34
thymus, fetal, pool1	10043-101F7	235.55	85.83	33.67	0.62	1.04	0.21	7.27
thyroid carcinoma cell line:KHM-5M	10776-110G2	253.95	181.23	38.96	2.93	1.46	0.80	9.04
thyroid carcinoma cell line:TCO-1	10783-110G9	414.04	190.26	21.37	2.65	2.51	1.40	2.10
thyroid, adult, pool1	10028-101E1	304.39	106.84	36.58	0.65	1.12	0.56	8.58
thyroid, fetal, donor1	10060-101H6	216.47	44.82	15.29	3.43	1.58	1.32	3.95
tongue epidermis (fungiform papillae), donor1	10288-104F9	166.30	73.91	15.40	0.00	0.00	3.08	6.16
tongue, adult	10203-103F5	306.07	142.10	24.19	4.88	1.16	2.33	7.91
tongue, fetal, donor1	10059-101H5	306.21	68.57	23.65	3.94	0.39	0.00	4.73
tonsil, adult, pool1	10047-101G2	203.66	92.36	20.24	0.70	1.80	0.30	5.31
trachea, adult, pool1	10029-101E2	255.70	104.13	20.61	0.74	0.65	0.49	4.01
trachea, fetal, donor1	10058-101H4	246.20	60.40	16.93	3.08	1.15	2.31	4.62
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	207.25	135.69	17.01	2.13	1.06	0.71	5.31
transitional-cell carcinoma cell line:5637	10418-106C4	142.15	60.79	23.81	0.61	0.51	0.10	5.17
transitional-cell carcinoma cell line:JMSU1	10492-107B6	397.83	274.67	40.90	3.60	4.54	0.78	6.11
tridermal teratoma cell line:HGRT	10694-109G1	182.64	116.05	22.83	0.00	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	877.23	342.75	47.83	5.25	1.61	3.13	4.40
umbilical cord, fetal, donor1	10057-101H3	171.09	62.60	27.12	4.17	0.00	0.00	6.26
uterus, adult, pool1	10100-102D1	194.35	54.43	23.21	0.17	1.54	0.00	4.27
uterus, fetal, donor1	10055-101H1	354.77	88.05	29.69	5.63	2.56	1.02	3.58
vagina, adult	10204-103F6	341.19	85.30	22.62	0.65	0.00	0.00	3.23
vein, adult	10191-103E2	219.86	53.92	17.76	0.66	0.88	1.53	3.29
xeroderma pigentosum b cell line:XPL 17	10563-108A5	305.49	185.06	30.44	2.67	0.53	1.07	1.87